<SEC-DOCUMENT>0001193125-22-154041.txt : 20220518
<SEC-HEADER>0001193125-22-154041.hdr.sgml : 20220518
<ACCEPTANCE-DATETIME>20220518161234
ACCESSION NUMBER:		0001193125-22-154041
CONFORMED SUBMISSION TYPE:	424B7
PUBLIC DOCUMENT COUNT:		3
FILED AS OF DATE:		20220518
DATE AS OF CHANGE:		20220518

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Canopy Growth Corp
		CENTRAL INDEX KEY:			0001737927
		STANDARD INDUSTRIAL CLASSIFICATION:	MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			Z4
		FISCAL YEAR END:			0331

	FILING VALUES:
		FORM TYPE:		424B7
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-253399
		FILM NUMBER:		22939250

	BUSINESS ADDRESS:	
		STREET 1:		1 HERSHEY DRIVE
		CITY:			SMITH FALLS
		STATE:			A6
		ZIP:			K7A0A8
		BUSINESS PHONE:		855-558-9333

	MAIL ADDRESS:	
		STREET 1:		1 HERSHEY DRIVE
		CITY:			SMITH FALLS
		STATE:			A6
		ZIP:			K7A0A8
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B7
<SEQUENCE>1
<FILENAME>d348413d424b7.htm
<DESCRIPTION>424B7
<TEXT>
<HTML><HEAD>
<TITLE>424B7</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Filed pursuant to Rule 424(b)(7) <BR> Registration No. 333-253399<BR> </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>PROSPECTUS SUPPLEMENT </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>(to Prospectus dated February&nbsp;23, 2021) </B></P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g348413g02v02.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>4,257,129 Common Shares </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This prospectus supplement relates to the offer and sale from time to time of up to 4,257,129 of our common shares, or the Shares, by the
selling securityholders listed in the section of this prospectus supplement entitled &#147;Selling Securityholders,&#148; or the Selling Securityholders. The Shares were issued to the Selling Securityholders in connection with the execution of an
Option Agreement, dated as of May&nbsp;17, 2022, by and among us, Canopy Oak LLC, our wholly-owned subsidiary, or Canopy Oak, Lemurian, Inc., a California corporation, or Lemurian, and the other parties thereto, and an Option Agreement, dated as of
May&nbsp;17, 2022, by and among Canopy Oak and the other parties thereto, or, together, the Option Agreements. Pursuant to the Option Agreements, Canopy Oak has the right, upon federal permissibility of THC in the United States, to acquire up to
100% of the outstanding capital stock of Lemurian. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our registration of the Shares covered by this prospectus supplement does not mean
that the Selling Securityholders will offer or sell any of the Shares. The Selling Securityholders may sell the Shares covered by this prospectus supplement in a number of different ways and at varying prices. For additional information on the
possible methods of sale that may be used by the Selling Securityholders, you should refer to the section of this prospectus supplement entitled &#147;Plan of Distribution&#148; beginning on page S-7 of this prospectus supplement. We will not
receive any of the proceeds from the Shares sold by the Selling Securityholders. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">You should read this prospectus supplement and the
accompanying prospectus carefully before you invest. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:12pt; font-family:Times New Roman"><B><I>Investing
in our common shares, or Common Shares, involves a high degree of risk. You should review carefully the risks and uncertainties described under the heading &#147;Item&nbsp;1A. Risk Factors&#148; beginning on page 24 of our Annual Report on Form <FONT
STYLE="white-space:nowrap">10-K</FONT> for the year ended March&nbsp;31, 2021, or the Annual Report, which is incorporated by reference in this prospectus supplement and the accompanying prospectus, as well as the risk factors discussed in the
periodic reports and other documents we file from time to time with the Securities and Exchange Commission, or the SEC, and which we incorporate into this prospectus supplement and accompanying prospectus by reference. See also &#147;<A HREF="#supptx348413_2">Risk
 Factors</A>&#148; beginning on page <FONT STYLE="white-space:nowrap">S-2</FONT> of this prospectus supplement and page 8 of the accompanying prospectus. </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our Common Shares are listed and posted for trading on the Toronto Stock Exchange (the &#147;TSX&#148;) under the symbol &#147;WEED&#148; and
on the Nasdaq Global Market (&#147;NASDAQ&#148;) under the symbol &#147;CGC&#148;. On May&nbsp;17, 2022, the last reported sales price for our Common Shares on NASDAQ was $5.89 per share. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Neither the SEC nor any state securities commission has approved or disapproved of these securities or determined if this prospectus
supplement is truthful or complete. Any representation to the contrary is a criminal offense. </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>The date of
this prospectus supplement is May&nbsp;18, 2022 </B></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc"></A>TABLE OF CONTENTS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Prospectus Supplement </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="95%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>Page</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supptx348413_1">About this Prospectus Supplement</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-1</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supptx348413_2">Risk Factors</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">S-2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supptx348413_3">Use of Proceeds</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">S-3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supptx348413_4">Selling Securityholders</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">S-4</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supptx348413_5">Plan of Distribution</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">S-7</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supptx348413_6">Legal Matters</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">S-9</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supptx348413_7">Experts</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">S-9</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supptx348413_8">Incorporation of Certain Documents by Reference</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">S-10</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Prospectus</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>Page</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx348413_1">About This Prospectus</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx348413_2">Where You Can Find More Information</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx348413_3">Cautionary Statement Regarding Forward-Looking Statements</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx348413_4">Risk Factors</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">8</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx348413_5">Canopy Growth Corporation</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">11</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx348413_6">Use of Proceeds</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">17</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx348413_7">Description of Securities</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">18</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx348413_8">Certain Income Tax Considerations</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">23</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx348413_9">Selling Securityholders</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">23</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx348413_10">Plan of Distribution</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">24</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx348413_11">Legal Matters</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">27</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx348413_12">Experts</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">27</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx348413_13">Enforcement of Civil Liabilities</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">27</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-i </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supptx348413_1"></A>ABOUT THIS PROSPECTUS SUPPLEMENT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On February&nbsp;23, 2021, we filed with the SEC a registration statement on Form <FONT STYLE="white-space:nowrap">S-3</FONT> (File <FONT
STYLE="white-space:nowrap">No.&nbsp;333-253399)</FONT> utilizing a shelf registration process relating to certain securities, including the securities described in this prospectus supplement, which registration statement became effective
automatically upon filing. This document is in two parts. The first part is this prospectus supplement, which describes the specific terms of this offering. The second part, the accompanying prospectus, gives more general information, some of which
may not apply to this offering and some of which may have been supplemented or superseded by information in this prospectus supplement or documents incorporated or deemed to be incorporated by reference into this prospectus supplement that we filed
with the SEC subsequent to the date of the prospectus. If information in the prospectus supplement is inconsistent with the accompanying base prospectus, you should rely on this prospectus supplement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This prospectus supplement does not constitute, and may not be used in connection with, an offer to sell, or a solicitation of an offer to
buy, the Shares offered by this prospectus supplement by any person in any jurisdiction in which it is unlawful for such person to make such an offer or solicitation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">It is important for you to read and consider all of the information contained in this prospectus supplement and the accompanying prospectus in
making your investment decision. This prospectus supplement, together with the accompanying prospectus and the documents incorporated by reference herein and therein, includes all material information relating to this offering. Please carefully read
both this prospectus supplement and the accompanying prospectus, together with the additional information described below under &#147;Important Information Incorporated by Reference&#148;. You also should read and consider the information in the
documents we have referred you to in the section titled &#147;Where You Can Find More Information&#148; on page 1 of the accompanying prospectus. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supptx348413_2"></A>RISK FACTORS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Investing in our Common Shares involves a high degree of risk. Before making an investment decision, you should carefully consider the risks
described under &#147;Item 1A Risk Factors&#148; in our Annual Report or in any updates in our Quarterly Reports on Form <FONT STYLE="white-space:nowrap">10-Q,</FONT> together with all of the other information appearing in or incorporated by
reference into this prospectus supplement, before deciding whether to purchase any of the Common Shares being offered. Our business, financial condition or results of operations could be materially adversely affected by any of these risks. The
trading price of our Common Shares could decline due to any of these risks, and you may lose all or part of your investment. Please also read carefully the section titled &#147;Cautionary Note Regarding Forward-Looking Statements.&#148; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supptx348413_3"></A>USE OF PROCEEDS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We will receive no proceeds from the sale of the Shares by the Selling Securityholders. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Selling Securityholders will pay any underwriting fees, discounts and commissions attributable to the sale of the Shares and any similar
expenses it incurs in disposing of the Shares. We will bear all other costs, fees and expenses incurred in effecting the registration of the Shares covered by this prospectus supplement. These may include, without limitation, all registration and
filing fees, printing fees and fees and expenses of our counsel and accountants in connection with the registration of the Shares covered by this prospectus supplement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supptx348413_4"></A>SELLING SECURITYHOLDERS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unless the context otherwise requires, as used in this prospectus supplement, &#147;Selling Securityholders&#148; include the selling
securityholders listed below and donees, pledgees, permitted transferees or other <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">successors-in-interest</FONT></FONT> selling shares received after the date of this prospectus
supplement from a selling securityholder as a gift, pledge or other <FONT STYLE="white-space:nowrap">non-sale</FONT> related transfer. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We
have prepared this prospectus supplement to allow the Selling Securityholders or their successors, assignees or other permitted transferees to sell or otherwise dispose of, from time to time, up to 4,257,129 of our Common Shares. The Shares were
issued to the Selling Securityholders in connection with the execution of the Option Agreements, pursuant to which Canopy Oak has the right, upon federal permissibility of THC in the United States, to acquire up to 100% of the outstanding capital
stock of Lemurian. Pursuant to the Option Agreements, we agreed to register for resale the Common Shares that we issued thereunder. The Shares were issued to the Selling Securityholders in reliance on the exemption from securities registration in
Section&nbsp;4(a)(2) under the Securities Act. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Shares to be offered by the Selling Securityholders pursuant to this prospectus
supplement are &#147;restricted&#148; securities under applicable federal and state securities laws and are being registered under the Securities Act to give the Selling Securityholders the opportunity to sell the Shares publicly. The registration
of the Shares does not require that any of the Shares be offered or sold by the Selling Securityholders. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">No estimate can be given as to
the amount or percentage of Common Shares that will be held by the Selling Securityholders after any sales made pursuant to this prospectus supplement because the Selling Securityholders are not required to sell any of the Shares being registered
hereunder. The table below assumes that the Selling Securityholders will sell all of the Shares listed in this prospectus supplement and no purchases of additional Common Shares. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unless otherwise indicated in the footnotes to the table below, no Selling Securityholder has had any material relationship with us or any of
our affiliates within the past three years other than as a security holder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have prepared the table below based on written
representations and information furnished to us by or on behalf of the Selling Securityholders. Since the date on which the Selling Securityholders provided this information, the Selling Securityholders may have sold, transferred or otherwise
disposed of all or a portion of the Common Shares in a transaction exempt from the registration requirements of the Securities Act. Unless otherwise indicated in the footnotes to the table below, we believe that (1)&nbsp;none of the Selling
Securityholders are broker-dealers or affiliates of a broker-dealer, (2)&nbsp;no Selling Securityholder has direct or indirect agreements or understandings with any person to distribute their Shares, and (3)&nbsp;the Selling Securityholders have
sole voting and investment power with respect to all Shares beneficially owned, subject to applicable community property laws. To the extent any Selling Securityholder is, or is affiliated with, a broker-dealer, it could be deemed to be, under SEC
Staff interpretations, an &#147;underwriter&#148; within the meaning of the Securities Act. Information about the Selling Securityholders may change over time. Any changed information will be set forth in supplements to this prospectus supplement,
if required. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table sets forth information with respect to the beneficial ownership of our Common Shares held, as of
May&nbsp;17, 2022, by the Selling Securityholders and the number of Shares being offered hereby and information with respect to Common Shares to be beneficially owned by the Selling Securityholders after
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
completion of this offering. The percentages in the following table reflect the Common Shares beneficially owned by the Selling Securityholders as a percentage of the total number of Common
Shares outstanding as of May&nbsp;17, 2022. As of such date, 398,688,602 Common Shares were outstanding. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="45%"></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total&nbsp;Number&nbsp;of&nbsp;Common&nbsp;Shares<BR>Beneficially&nbsp;Owned&nbsp;Prior&nbsp;to&nbsp;the<BR>Offering <SUP
STYLE="font-size:85%; vertical-align:top">(1)</SUP></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Maximum&nbsp;Number&nbsp;of<BR>Common&nbsp;Shares&nbsp;that&nbsp;may<BR>be&nbsp;Offered&nbsp;Pursuant&nbsp;to&nbsp;this<BR>Prospectus
Supplement</B></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Common Shares<BR>Beneficially&nbsp;Owned<BR>After&nbsp;this&nbsp;Offering&nbsp;<SUP STYLE="font-size:85%; vertical-align:top">(1)(2)</SUP></B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Name</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Percentage</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Percentage</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Abraham Dorfman</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">80,336</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">80,336</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Blue Dream IX LLC<SUP STYLE="font-size:85%; vertical-align:top">(3)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">35,164</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">35,164</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Christian Yegen</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">104,173</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">104,173</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Christopher Yegen</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">11,763</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">11,763</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Marine Layer Capital LLC<SUP STYLE="font-size:85%; vertical-align:top">(4)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,518,561</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,518,561</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Dan Gershoni</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">25,410</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">25,410</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Dushyant Mehra</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10,550</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10,550</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Himanshu Mehra</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3,517</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3,517</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Itzhak Gershoni</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">26,814</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">26,814</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Jason Aaron Harris</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">23,606</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">23,606</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Jerome L. Brenner</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7,033</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7,033</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">JGG LLC<SUP STYLE="font-size:85%; vertical-align:top">(5)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">16,879</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">16,879</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">JML Family Trust dated
February&nbsp;28,&nbsp;2018<SUP STYLE="font-size:85%; vertical-align:top">(6)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10,034</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">9,484</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">550</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Kenneth Greif</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4,712</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4,712</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Larry Horn</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4,712</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4,712</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Marla Rowe</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">41,169</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">41,169</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Michael Lee</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">23,391</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">23,391</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Michael James McDonald</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">74,508</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">74,508</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Nathan Ferguson</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">451,340</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">451,340</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Omer Peleg</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">25,458</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">25,458</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Amiram Peleg&nbsp;&amp; Rahel Peleg JT TEN</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">25,459</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">25,459</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Yoav Barlev</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">25,458</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">25,458</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Mark Rogero</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">18,607</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">18,524</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">83</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Parts4Laser LLP<SUP STYLE="font-size:85%; vertical-align:top">(7)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">68,797</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">68,797</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Reuven Gershoni</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">172,228</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">160,028</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">12,200</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Robert Ferguson</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">66,423</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">66,235</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">188</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Ron A. Gershoni</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">363,289</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">363,289</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Sanjay Tolia</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">14,848</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">14,848</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">VCo Ventures LLC<SUP STYLE="font-size:85%; vertical-align:top">(8)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">846,237</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">846,237</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Vinay Vaswani</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">17,965</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">17,965</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">William Kohane</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4,642</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4,642</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Chi Lee</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">68,616</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">68,616</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Apple Core Holdings LLC<SUP STYLE="font-size:85%; vertical-align:top">(9)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">61,291</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">61,291</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Ross Goodhart</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,043</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,043</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Kirit Tolia</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4,086</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4,086</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Eric Metz</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,451</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,451</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">JNR MC Capital Advisors, LLC<SUP STYLE="font-size:85%; vertical-align:top">(10)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4,086</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4,086</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Elan Gershoni</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,634</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,634</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Gerald Derevyanny</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">817</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">817</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Brad Kotansky</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,043</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,043</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>TOTAL</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>4,270,150</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1.07</B></TD>
<TD NOWRAP VALIGN="bottom"><B>%&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>4,257,129</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>13,021</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">*</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Represents less than 1% of the issued and outstanding Common Shares. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Beneficial ownership is determined in accordance with Rule <FONT STYLE="white-space:nowrap">13d-3</FONT> under
the Securities Exchange Act of 1934, as amended, or the Exchange Act. In computing the number of Common Shares beneficially owned by a person and the percentage ownership of that person, Common Shares subject to warrants, options and other
convertible securities held by that person that are currently exercisable or exercisable within 60 days (of May&nbsp;17, 2022) are deemed outstanding. Common Shares subject to warrants, options and other convertible securities, however, are not
deemed outstanding for the purpose of computing the percentage ownership of any other person. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Assumes that the Selling Securityholders dispose of all of the Common Shares covered by this prospectus
supplement and does not acquire beneficial ownership of any additional Common Shares. The registration of these Common Shares does not necessarily mean that the Selling Securityholders will sell all or any portion of the Common Shares covered by
this prospectus supplement. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Blue Dream IX LLC is governed by a three-member board of managers, consisting of Greg Hersly, Marc Gare and
Chris Mayle. As such, Greg Hersly, Marc Gare and Chris Mayle share power and authority to vote and dispose of the securities held of record by Blue Dream IX LLC. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Sanjay Tolia is the Managing Member of Marine Layer Capital LLC and has the power and authority to vote and
dispose of the securities held of record by Marine Layer Capital LLC. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(5)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">IRA Financial Trust Company, Custodian For The Benefit Of The Justin Gamble Gregory IRA is the Member of JGG
LLC. Justin Gregory is the Manager and has sole power and authority to vote and dispose of the securities held of record by JGG LLC. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(6)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Jonathan Littrell is the Trustee of the JML Family Trust dated February&nbsp;28, 2018 and has the power and
authority to vote and dispose of the securities held of record by the JML Family Trust dated February&nbsp;28, 2018. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(7)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Yoram Illouz and Ronen Betzalel are the Partners of Parts4Laser LLP and have the joint power and authority to
vote and dispose of the securities held of record by Parts4Laser LLP. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(8)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Agustin Huneeus is the Managing Member of VCo Ventures LLC and has the power and authority to vote and dispose
of the securities held of record by VCo Ventures LLC. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(9)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">David Miller and Steve Klein are the Managing Members of Apple Core Holdings LLC and each, individually, have
the power and authority to vote and dispose of the securities held of record by Apple Core Holdings LLC. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(10)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Joshua Rosen is the Managing Member of JNR MC Capital Advisors, LLC and has the power and authority to vote and
dispose of the securities held of record by JNR MC Capital Advisors, LLC. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supptx348413_5"></A>PLAN OF DISTRIBUTION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are registering the Shares to permit the resale of the Shares by the holders thereof from time to time after the date of this prospectus
supplement. We will not receive any of the proceeds from the sale by the Selling Securityholders of the Shares. We will bear all fees and expenses incident to our obligation to register the Shares. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Selling Securityholders may sell all or a portion of the Shares beneficially owned by them and offered hereby from time to time directly
or through one or more underwriters, broker-dealers or agents. If the Shares are sold through underwriters or broker-dealers, the Selling Securityholders will be responsible for underwriting fees, discounts or commissions or agent&#146;s
commissions. The Shares may be sold in one or more transactions at fixed prices, at prevailing market prices at the time of the sale, at varying prices determined at the time of sale, or at negotiated prices. The Selling Securityholders will act
independently of us in making decisions with respect to the timing, manner and size of each sale. These sales may be effected in transactions, which may involve cross or block transactions. The Selling Securityholders may use one or more of the
following methods when disposing of the Shares or interests therein: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">on any national securities exchange or quotation service on which the securities may be listed or quoted at the
time of sale; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">in the <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">over-the-counter</FONT></FONT> market;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">in transactions otherwise than on these exchanges or systems or in the <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">over-the-counter</FONT></FONT> market; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">through the writing of options, whether such options are listed on an options exchange or otherwise;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">in ordinary brokerage transactions and transactions in which the broker-dealer solicits purchasers;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">in block trades in which the broker-dealer will attempt to sell the shares as agent but may position and resell a
portion of the block as principal to facilitate the transaction; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">through purchases by a broker-dealer as principal and resale by the broker-dealer for its account;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">in an exchange distribution in accordance with the rules of the applicable exchange; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">in privately negotiated transactions; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">in short sales; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">through the distribution of the Shares by the Selling Securityholders to its partners, members or stockholders;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">through one or more underwritten offerings on a firm commitment or best efforts basis; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">in sales pursuant to Rule 144; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">whereby broker-dealers may agree with the Selling Securityholders to sell a specified number of such Shares at a
stipulated price per share; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">in a combination of any such methods of sale; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">in any other method permitted pursuant to applicable law. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If the Selling Securityholders effect such transactions by selling Shares to or through underwriters, broker-dealers or agents, such
underwriters, broker-dealers or agents may receive commissions in the form of discounts, concessions or commissions from the Selling Securityholders or commissions from purchasers of the Shares for whom they may act as agent or to whom they may sell
as principal (which discounts, concessions or commissions as to particular underwriters, broker-dealers or agents may be in excess of those customary in the types of transactions involved). In connection with sales of the Shares or otherwise, the
Selling Securityholders may enter into hedging transactions with broker-dealers, which may in turn engage in short sales of the Shares in the course of hedging in positions they assume. The Selling Securityholders may also sell the Shares short and
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
deliver Shares covered by this prospectus supplement to close out short positions and to return borrowed Common Shares in connection with such short sales. The Selling Securityholders may also
loan or pledge Common Shares to broker-dealers that in turn may sell such Common Shares. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Selling Securityholders may pledge or grant
a security interest in some or all of the Common Shares owned by them and, if they default in the performance of their secured obligations, the pledgees or secured parties may offer and sell the Common Shares from time to time pursuant to this
prospectus supplement or any amendment to this prospectus supplement under Rule 424(b)(3) or other applicable provision of the Securities Act amending, if necessary, the list of Selling Securityholders to include the pledgee, transferee or other
successors in interest as Selling Securityholders under this prospectus supplement. The Selling Securityholders also may transfer and donate the Common Shares in other circumstances in which case the transferees, donees, pledgees or other successors
in interest will be the selling beneficial owners for purposes of this prospectus supplement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Selling Securityholders, individually
and not severally, and any broker-dealer participating in the distribution of the Shares may be deemed to be &#147;underwriters&#148; within the meaning of the Securities Act, and any commission paid, or any discounts or concessions allowed to, any
such broker-dealer may be deemed to be underwriting commissions or discounts under the Securities Act. At the time a particular offering of the Shares is made, a prospectus supplement, if required, will be distributed which will set forth the
aggregate amount of Shares being offered and the terms of the offering, including the name or names of any broker-dealers or agents, any discounts, commissions and other terms constituting compensation from the Selling Securityholders and any
discounts, commissions or concessions allowed or reallowed or paid to broker-dealers. The Selling Securityholders may indemnify any broker-dealer that participates in transactions involving the sale of the Shares against certain liabilities,
including liabilities arising under the Securities Act. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under the securities laws of some states, the Shares may be sold in such states
only through registered or licensed brokers or dealers. In addition, in some states, the Shares may not be sold unless such Shares have been registered or qualified for sale in such state or an exemption from registration or qualification is
available and is complied with. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The aggregate proceeds to the Selling Securityholders from the sale of the Shares offered will be the
purchase price of the Shares less discounts or commissions, if any. The Selling Securityholders reserve the right to accept and, together with their agents from time to time, to reject, in whole or in part, any proposed purchase of Shares to be made
directly or through agents. There can be no assurance that any Selling Securityholders will sell any or all of the Shares registered hereunder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Selling Securityholders and any other person participating in such distribution will be subject to applicable provisions of the Exchange
Act and the rules and regulations thereunder, including, without limitation, Regulation M of the Exchange Act, which may limit the timing of purchases and sales of any of the Shares by the Selling Securityholders and any other participating person.
Regulation M may also restrict the ability of any person engaged in the distribution of the Shares to engage in market-making activities with respect to the Shares. All of the foregoing may affect the marketability of the Shares and the ability of
any person or entity to engage in market-making activities with respect to the Shares. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We will pay all expenses of the registration of
the Shares pursuant to the Option Agreements, including, without limitation, SEC filing fees and expenses of compliance with state securities or &#147;Blue Sky&#148; laws; <I>provided</I>,<I> however</I>, that a Selling Securityholder will pay all
underwriting fees, discounts or commissions attributable to the sale of the Shares or any legal fees and expenses of counsel to the Selling Securityholders, if any. We may be indemnified by the Selling Securityholders against certain liabilities,
including certain liabilities under the Securities Act or the Exchange Act, that may arise from any written information furnished to us by the Selling Securityholder specifically for use in this prospectus supplement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Once sold hereunder, the Shares will be freely tradable in the hands of persons other than our affiliates. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supptx348413_6"></A>LEGAL MATTERS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The validity of the Common Shares offered by this prospectus supplement and certain other Canadian legal matters related to the Common Shares
being offered by this prospectus supplement will be passed upon for us by Cassels Brock&nbsp;
&amp; Blackwell LLP. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supptx348413_7"></A>EXPERTS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The consolidated financial statements of Canopy Growth Corporation as of March&nbsp;31, 2021 and 2020, and for each of the years in the
three-year period ended March&nbsp;31, 2021, and management&#146;s assessment of the effectiveness of internal control over financial reporting as of March&nbsp;31, 2021, have been incorporated by reference herein in reliance on the reports of KPMG
LLP, independent registered public accounting firm, incorporated by reference herein, and upon the authority of said firm as experts in auditing and accounting.</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supptx348413_8"></A>INCORPORATION OF CERTAIN DOCUMENTS BY REFERENCE </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The SEC allows us to &#147;incorporate by reference&#148; information into this prospectus supplement, which means that we can disclose
important information to you by referring you to another document filed separately with the SEC. The documents incorporated by reference into this prospectus supplement contain important information that you should read about us. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following documents are incorporated by reference into this prospectus supplement: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Our Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the fiscal year ended <A HREF="http://www.sec.gov/Archives/edgar/data/1737927/000156459021031214/cgc-10k_20210331.htm">March&nbsp;31,
 2021</A>, filed with the SEC on June&nbsp;1, 2021; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Our Quarterly Report on Form <FONT STYLE="white-space:nowrap">10-Q</FONT> for the quarter ended <A HREF="http://www.sec.gov/Archives/edgar/data/1737927/000156459021042161/cgc-10q_20210630.htm">June&nbsp;30,
 2021</A>, filed with the SEC on <A HREF="http://www.sec.gov/Archives/edgar/data/1737927/000156459021042161/cgc-10q_20210630.htm">August&nbsp;6, 2021</A>, our Quarterly Report on Form <FONT STYLE="white-space:nowrap">10-Q</FONT> for the quarter
ended <A HREF="http://www.sec.gov/Archives/edgar/data/1737927/000156459021055275/cgc-10q_20210930.htm">September&nbsp;30, 2021</A> filed with the SEC on November&nbsp;8, 2021&nbsp;and our&nbsp;Quarterly Report on Form
<FONT STYLE="white-space:nowrap">10-Q</FONT> for the quarter ended <A HREF="http://www.sec.gov/Archives/edgar/data/1737927/000156459022004413/cgc-10q_20211231.htm">December&nbsp;31, 2021</A> filed with the SEC on February&nbsp;9, 2022;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Our Current Reports on Form <FONT STYLE="white-space:nowrap">8-K</FONT> filed with the SEC on <A HREF="http://www.sec.gov/Archives/edgar/data/1737927/000119312521114656/d131520d8k.htm">April&nbsp;13,
 2021</A> (excluding information under Item 7.01), <A HREF="http://www.sec.gov/Archives/edgar/data/1737927/000119312521189153/d166505d8k.htm">June&nbsp;
14, 2021</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/1737927/000119312521273858/d232907d8k.htm">September&nbsp;15, 2021</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/1737927/000119312521276301/d197556d8k.htm">September&nbsp;20,
2021</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/1737927/000119312521298814/d404994d8k.htm">October&nbsp;14, 2021</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/1737927/000119312521340492/d269370d8k.htm">November&nbsp;24, 2021</A>
(excluding information under Item 7.01), <A HREF="http://www.sec.gov/Archives/edgar/data/1737927/000119312521342243/d243611d8k.htm">November&nbsp;
29, 2021</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/1737927/000119312521357918/d172316d8k.htm">December&nbsp;15, 2021</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/1737927/000119312522095047/d292368d8k.htm">April&nbsp;4, 2022</A>
(excluding information under Item 7.01), <A HREF="http://www.sec.gov/Archives/edgar/data/1737927/000119312522134128/d209775d8k.htm">April&nbsp;29, 2022</A> (excluding information under Item 2.02) and May&nbsp;18, 2022; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Our definitive proxy statement on Schedule 14A filed with the SEC on <A HREF="http://www.sec.gov/Archives/edgar/data/1737927/000114036121026063/nc10026696x2_def14a.htm">July&nbsp;29,
 2021</A> (solely to the extent incorporated by reference into Part III of our Annual Report on <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/1737927/000156459021031214/cgc-10k_20210331.htm">Form <FONT
STYLE="white-space:nowrap">10-K</FONT></A> for the fiscal year ended March&nbsp;31, 2021); and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(e)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The description of our Common Shares contained in our Registration Statement on Form <FONT
STYLE="white-space:nowrap">8-A/A</FONT> (File <FONT STYLE="white-space:nowrap">No.&nbsp;001-38496),</FONT> filed with the SEC on <A HREF="http://www.sec.gov/Archives/edgar/data/1737927/000119312520292731/d28363d8a12ba.htm">November&nbsp;13,
2020</A>, and any amendment or report filed for the purpose of updating any such description. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">All documents filed by us
pursuant to Sections 13(a), 13(c), 14 or 15(d) of the Exchange Act after the date of this prospectus supplement and before the termination of the offering also shall be deemed to be incorporated herein by reference. We are not, however,
incorporating by reference any documents or portions thereof that are not deemed &#147;filed&#148; with the SEC, including any information furnished pursuant to Items 2.02 or 7.01 of Form <FONT STYLE="white-space:nowrap">8-K.</FONT> Any statements
in any such future filings will automatically be deemed to modify and supersede any information in any document we previously filed with the SEC that is incorporated or deemed to be incorporated herein by reference to the extent that statements in
the later filed document modify or replace such earlier statements. Any such statement so modified or superseded shall not be deemed to constitute a part of this prospectus supplement, except as so modified or superseded. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If requested orally or in writing, we will provide to each person, including any beneficial owner, to whom a prospectus supplement is
delivered, at no cost, a copy of any or all of the information that has been incorporated by reference in this prospectus supplement but not delivered with this prospectus supplement. Exhibits to the filings will not be sent, however, unless those
exhibits have specifically been incorporated by reference into such documents. To obtain a copy of these filings at no cost, you may write or telephone us at the following address: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Canopy Growth Corporation </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1
Hershey Drive </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Smiths Falls, Ontario, Canada K7A 0A8 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(855) <FONT STYLE="white-space:nowrap">558-9333(403)</FONT> </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Attention: Chief Legal Officer </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Prospectus </B></P> <P STYLE="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g348413g02v02.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:10pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>Common Shares </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>Subscription Receipts </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>Units </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>Warrants </B></P>
<P STYLE="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:10pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We may from time to time offer and sell our common shares (&#147;Common Shares&#148;), subscription receipts (&#147;Subscription
Receipts&#148;), units (&#147;Units&#148;) and warrants (&#147;Warrants&#148;) (collectively, the &#147;Securities&#148;). Securities may be offered separately or together, in amounts, at prices and on terms to be determined based on market
conditions at the time of sale and set forth in one or more prospectus supplements. These Securities may be offered and sold in the United States and elsewhere where permitted by law. We will provide the specific terms of these Securities in
supplements to this prospectus that will be delivered to purchasers together with this prospectus. You should read this prospectus and any prospectus supplement carefully before you invest in the Securities. </P>
<P STYLE="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:10pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>This prospectus may not be used to sell the Securities unless accompanied by a prospectus supplement. </B></P>
<P STYLE="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:10pt; margin-bottom:0pt; text-indent:4%; font-size:12pt; font-family:Times New Roman"><B>Investment in the Securities involves certain risks that should be considered by a prospective purchaser. See &#147;<A HREF="#tx348413_4">Risk
 Factors</A>&#148; on page 8 of this prospectus along with the risk factors described in the applicable prospectus supplement pertaining to the Securities and the other information contained in and incorporated by reference in this prospectus and in
the applicable prospectus supplement before purchasing the Securities offered hereby. See &#147;Where You Can Find More Information&#148;. </B></P>
<P STYLE="margin-top:10pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We may sell the Securities to or through underwriters or dealers purchasing as principals and may also sell the Securities to one or more
purchasers directly or through agents. See &#147;Plan of Distribution&#148;. The prospectus supplement relating to a particular offering of Securities will identify each underwriter, dealer or agent, as the case may be, engaged by us in connection
with the offering and sale of Securities, and will set forth the terms of the offering of such Securities, including the method of distribution of such Securities, the public offering price, the proceeds to us, any fees, discounts or other
compensation payable to underwriters, dealers or agents, and any other material terms of the plan of distribution. </P> <P STYLE="margin-top:10pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our Common Shares are
listed and posted for trading on the Toronto Stock Exchange (the &#147;<B>TSX</B>&#148;) under the symbol &#147;WEED&#148; and on the Nasdaq Global Market (&#147;<B>NASDAQ</B>&#148;) under the symbol &#147;CGC&#148;. <B>Unless otherwise specified in
the applicable prospectus supplement, the Subscription Receipts, Units and Warrants will not be listed on any securities or stock exchange.</B> </P>
<P STYLE="margin-top:10pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Neither the United States Securities and Exchange Commission (the &#147;SEC&#148;) nor any state securities commission has approved or
disapproved of these Securities or determined if this prospectus is truthful or complete. Any representation to the contrary is a criminal offence. </B></P> <P STYLE="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>The date of
this prospectus is February 23, 2021 </B></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>TABLE OF CONTENTS </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="97%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx348413_1">ABOUT THIS PROSPECTUS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx348413_2">WHERE YOU CAN FIND MORE INFORMATION</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx348413_3">CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx348413_4">RISK FACTORS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">8</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx348413_5">CANOPY GROWTH CORPORATION</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">11</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx348413_6">USE OF PROCEEDS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">17</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx348413_7">DESCRIPTION OF SECURITIES</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">18</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx348413_8">CERTAIN INCOME TAX CONSIDERATIONS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">23</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx348413_9">SELLING SECURITYHOLDERS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">23</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx348413_10">PLAN OF DISTRIBUTION</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">24</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx348413_11">LEGAL MATTERS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">27</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx348413_12">EXPERTS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">27</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx348413_13">ENFORCEABILITY OF CIVIL LIABILITIES</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">27</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">i </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx348413_1"></A>ABOUT THIS PROSPECTUS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This prospectus is part of an &#147;automatic shelf&#148; registration statement that we filed with the SEC as a &#147;well- known seasoned
issuer&#148; as defined in Rule 405 under the Securities Act of 1933, as amended (the &#147;<B>Securities Act</B>&#148;), using a &#147;shelf&#148; registration process. Under this process, we may sell from time to time any combination of the
Securities described in this prospectus. This prospectus only provides you with a general description of the Securities that we may offer. Each time we sell Securities, we will provide a supplement to this prospectus that contains specific
information about the terms of that offering, including the specific amounts, prices and terms of the Securities offered. The prospectus supplement may also add, update or change information contained in this prospectus. You should carefully read
both this prospectus, any accompanying prospectus supplement and any free writing prospectus prepared by or on behalf of us, together with the additional information described under the heading &#147;Where You Can Find More Information.&#148; This
prospectus does not contain all of the information set forth in the Registration Statement we have filed with the SEC of which this prospectus forms a part, certain parts of which are omitted in accordance with the rules and regulations of the SEC.
You may refer to the Registration Statement of which this prospectus forms a part and the exhibits to the Registration Statement for further information with respect to us and the Securities. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have not authorized anyone to provide you with any information other than that contained in or incorporated by reference into this
prospectus, any accompanying prospectus supplement and any free writing prospectus prepared by or on behalf of us. We take no responsibility for, and can provide no assurance as to the reliability of, any other information that others may give you.
We are not making offers to sell the Securities in any jurisdiction in which an offer or solicitation is not authorized or in which the person making such offer or solicitation is not qualified to do so or to anyone to whom it is unlawful to make an
offer or solicitation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The information in this prospectus is accurate as of the date on the front cover. You should not assume that the
information contained in this prospectus is accurate as of any other date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unless the context otherwise requires, all references in this
prospectus and any prospectus supplement to &#147;Canopy Growth&#148;, the &#147;Corporation&#148;, &#147;we&#148;, &#147;us&#148; and &#147;our&#148; mean Canopy Growth Corporation and its consolidated subsidiaries and partnerships. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In this prospectus and in any prospectus supplement, unless otherwise specified or the context otherwise requires, all dollar amounts are
expressed in United States dollars, references to &#147;dollars&#148;, &#147;$&#148; or &#147;US$&#148; are to United States dollars and all references to &#147;C$&#148; are to Canadian dollars. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unless otherwise indicated, all financial information included and incorporated by reference in this prospectus or included in any prospectus
supplement is determined using U.S. generally accepted accounting principles. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx348413_2"></A>WHERE YOU CAN FIND MORE INFORMATION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We file annual, quarterly and current reports, proxy statements and other information with the SEC under the Securities Exchange Act of 1934,
as amended (the &#147;<B>Exchange Act</B>&#148;). Under the multijurisdictional disclosure system adopted by Canada and the United States, reports filed or furnished by us prior to April 1, 2020 with the SEC have been prepared in accordance with the
disclosure requirements of Canada, which requirements are different from those of the United States. You may read and copy all or any portion of this information at the Public Reference Room of the SEC at 100 F Street, N.E., Washington, D.C. 20549.
Please call the SEC at <FONT STYLE="white-space:nowrap">1-800-SEC-0330</FONT> for further information about the Public Reference Room. The SEC also maintains an Internet site that contains reports, proxy and information statements, and other
information regarding issuers that file electronically with the SEC, including Canopy Growth, at www.sec.gov. Canopy Growth&#146;s SEC filings are also available on Canopy Growth&#146;s website at www.canopygrowth.com. Information on or connected to
our website, even if referred to in documents incorporated by reference in this prospectus, does not constitute part of this prospectus. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The SEC allows us to &#147;incorporate by reference&#148; information into this prospectus and any accompanying prospectus supplement, which
means that we can disclose important information to you by referring you to another document filed separately with the SEC. The information incorporated by reference is deemed to be part of this prospectus and any accompanying prospectus supplement,
except for any information superseded by information contained directly in this prospectus, any accompanying prospectus supplement, any subsequently filed document deemed incorporated by reference or any free writing prospectus prepared by or on
behalf of us. This prospectus and any accompanying prospectus supplement incorporate by reference the documents set forth below that we have previously filed with the SEC (other than information deemed furnished and not filed in accordance with SEC
rules, including Items 2.02 and 7.01 of Form 8-K). </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Our Annual Report on Form 10-K for the fiscal year ended March 31, 2020, filed with the SEC on <A HREF="http://www.sec.gov/Archives/edgar/data/1737927/000156459020027897/cgc-10k_20200331.htm">June&nbsp;1,
 2020</A>; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Our Amendment to Annual Report on Form 10-K/A filed with the SEC on <A HREF="http://www.sec.gov/Archives/edgar/data/1737927/000114036120016963/form10ka.htm">July&nbsp;29,
 2020</A> to include Part III of our Annual Report on <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/1737927/000156459020027897/cgc-10k_20200331.htm">Form 10-K</A> for the fiscal year ended March&nbsp;31, 2020
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Our Quarterly Reports on Form 10-Q for the quarters ended June 30, 2020, filed with the SEC on <A HREF="http://www.sec.gov/Archives/edgar/data/1737927/000156459020038957/cgc-10q_20200630.htm">August
 10, 2020</A>, September 30, 2020, filed with the SEC on <A HREF="http://www.sec.gov/Archives/edgar/data/1737927/000156459020052540/cgc-10q_20200930.htm">November 9, 2020</A> and December&nbsp;
31, 2020 filed with the SEC on <A HREF="http://www.sec.gov/Archives/edgar/data/1737927/000156459021005014/cgc-10q_20201231.htm">February 9, 2021</A>; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Our Current Reports on Form 8-K, filed with the SEC on <A HREF="http://www.sec.gov/Archives/edgar/data/1737927/000119312520184004/d934311d8k.htm">June
<U></U>&nbsp;
30, 2020</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/1737927/000117184320006418/f8k_091020.htm">September 11, 2020</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/1737927/000117184320006568/f8k_092220.htm">September 22, 2020</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/1737927/000119312520252335/d60893d8k.htm">September
 23, 2020</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/1737927/000117184320007526/f8k_110320.htm">November 4, 2020</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/1737927/000156459020052119/cgc-8k_20201105.htm">November 9, 2020</A>
accepted on November&nbsp;6, 2020, <A HREF="http://www.sec.gov/Archives/edgar/data/1737927/000119312520314122/d22148d8k.htm">December&nbsp;
10, 2020</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/1737927/000119312520326922/d50302d8k.htm">December 28, 2020</A>; <A HREF="http://www.sec.gov/Archives/edgar/data/1737927/000119312521051735/d131705d8k.htm">February 23, 2021</A> and
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The description of our Common Shares contained in our Registration Statement on Form 8-A/A, filed with the SEC on
<A HREF="http://www.sec.gov/Archives/edgar/data/1737927/000119312520292731/d28363d8a12ba.htm">November 13, 2020</A>, and any amendment or report filed for the purpose of updating any such description. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">All documents filed by us pursuant to Sections 13(a), 13(c), 14 or 15(d) of the Exchange Act after the date of this prospectus and before the
termination of the offering also shall be deemed to be incorporated herein by reference. We are not, however, incorporating by reference any documents or portions thereof that are not deemed &#147;filed&#148; with the SEC, including any information
furnished pursuant to Items 2.02 or 7.01 of Form 8-K. Any statements in any such future filings will automatically be deemed to modify and supersede any information in any document we previously filed with the SEC that is incorporated or deemed to
be incorporated herein by reference to the extent that statements in the later filed document modify or replace such earlier statements. Any such statement so modified or superseded shall not be deemed to constitute a part of this prospectus, except
as so modified or superseded. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If requested orally or in writing, we will provide to each person, including any beneficial owner, to whom
a prospectus is delivered, at no cost, a copy of any or all of the information that has been incorporated by reference </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
in this prospectus but not delivered with this prospectus. Exhibits to the filings will not be sent, however, unless those exhibits have specifically been incorporated by reference into such
documents. To obtain a copy of these filings at no cost, you may write or telephone us at the following address: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Canopy Growth Corporation</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1 Hershey Drive</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Smiths Falls, Ontario, Canada K7A 0A8</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(855) 558-9333(403)</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Attention: Chief Legal Officer</P></TD></TR>
</TABLE></DIV>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx348413_3"></A>CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This prospectus contains or incorporates by reference &#147;forward-looking statements&#148; within the meaning of Section&nbsp;27A of the
Securities Act and Section&nbsp;21E of the Exchange Act and &#147;forward-looking information&#148; under applicable Canadian securities legislation (collectively, <FONT STYLE="white-space:nowrap">&#147;forward-looking</FONT> statements&#148;) and
other applicable securities laws, which involve certain known and unknown risks and uncertainties. In addition to the cautionary statement below, with respect to <FONT STYLE="white-space:nowrap">forward-looking</FONT> statements contained in the
documents incorporated by reference herein, prospective purchasers should refer to &#147;Note Regarding Forward-Looking Statements&#148; in the Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> of the Corporation as well as to
similar sections of any documents incorporated by reference in this prospectus that are filed after the date hereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Forward-looking
statements predict or describe the Corporation&#146;s future operations, business plans, business and investment strategies and the performance of the Corporation&#146;s investments. These forward-looking statements are generally identified by their
use of such terms and phrases as &#147;intend,&#148; &#147;goal,&#148; &#147;strategy,&#148; &#147;estimate,&#148; &#147;expect,&#148; &#147;project,&#148; &#147;projections,&#148; &#147;forecasts,&#148; &#147;plans,&#148; &#147;seeks,&#148;
&#147;anticipates,&#148; &#147;potential,&#148; &#147;proposed,&#148; &#147;will,&#148; &#147;should,&#148; &#147;could,&#148; &#147;would,&#148; &#147;may,&#148; &#147;likely,&#148; &#147;designed to,&#148; &#147;foreseeable future,&#148;
&#147;believe,&#148; &#147;scheduled&#148; and other similar expressions. The Corporation&#146;s actual results or outcomes may differ materially from those anticipated. Prospective investors are cautioned not to place undue reliance on these <FONT
STYLE="white-space:nowrap">forward-looking</FONT> statements, which speak only as of the date the statement was made. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Forward-looking
statements include, but are not limited to, statements with respect to: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the uncertainties associated with the <FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic, including the
Corporation&#146;s ability to continue operations, the ability of the Corporation&#146;s suppliers and distribution channels to continue to operate, the use of the Corporation&#146;s products by consumers, disruptions to the global and local
economies due to related <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">stay-at-</FONT></FONT> home orders, quarantine policies and restrictions on travel, trade and business operations and a reduction in discretionary consumer
spending; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">laws and regulations and any amendments thereto applicable to the Corporation&#146;s business and the impact
thereof, including uncertainty regarding the application of U.S. state and federal law to U.S. hemp (including hemp-derived cannabidiol (&#147;<B>CBD</B>&#148;)) products and the scope of any regulations by the U.S. Federal Drug Administration, the
U.S. Federal Trade Commission, the U.S. Patent and Trademark Office, the U.S. Department of Agriculture (the &#147;<B>USDA</B>&#148;) and any state equivalent regulatory agencies over U.S. hemp (including CBD) products; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">expectations regarding the regulation of the hemp industry in the U.S., including the promulgation of regulations
for the U.S. hemp industry by the USDA; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">expectations regarding the potential success of, and the costs and benefits associated with, the
Corporation&#146;s acquisitions, joint ventures, strategic alliances, equity investments and dispositions; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the Acreage Amended Arrangement (as defined below), including the satisfaction or waiver of the conditions to
closing of such acquisition; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the grant, renewal and impact of any license or supplemental license to conduct activities with cannabis or any
amendments thereof; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the Corporation&#146;s international activities and joint venture interests, including required regulatory
approvals and licensing, anticipated costs and timing, and expected impact; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the ability to successfully create and launch brands and further create, launch and scale cannabis-based products
and U.S. hemp-derived consumer products in jurisdictions where such products are legal and that the Corporation currently operates in; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the benefits, viability, safety, efficacy, dosing and social acceptance of cannabis, including CBD and other
cannabinoids; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the anticipated benefits and impact of the investments (the &#147;<B>CBI Group Investments</B>&#148;) made by
Constellation Brands, Inc. (&#147;<B>CBI</B>&#148;) and its affiliates (together, the &#147;<B>CBI Group</B>&#148;) in the Corporation; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the potential exercise of the warrants held by the CBI Group, <FONT STYLE="white-space:nowrap">pre-emptive</FONT>
rights and/or top-up rights in connection with the CBI Group Investments, including proceeds to the Corporation that may result therefrom or the potential conversion of senior convertible notes held by the CBI Group in connection with the CBI Group
Investments; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">expectations regarding the use of proceeds of equity financings, including pursuant to this prospectus, and the
proceeds from the CBI Group Investments; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the legalization of the use of cannabis for medical or recreational in jurisdictions outside of Canada, the
related timing and impact thereof and the Corporation&#146;s intentions to participate in such markets, if and when such use is legalized; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the Corporation&#146;s ability to execute on its strategy and the anticipated benefits of such strategy;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the ongoing impact of the legalization of cannabis product types and forms for recreational use in Canada,
including federal, provincial, territorial and municipal regulations pertaining thereto, the related timing and impact thereof and the Corporation&#146;s intentions to participate in such markets; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the ongoing impact of developing provincial, territorial and municipal regulations pertaining to the sale and
distribution of cannabis, the related timing and impact thereof, as well as the restrictions on federally regulated cannabis producers participating in certain retail markets and the Corporation&#146;s intentions to participate in such markets to
the extent permissible; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the future performance of the Corporation&#146;s business and operations; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the Corporation&#146;s competitive advantages and business strategies; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the competitive conditions of the industry; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the expected growth in the number of customers using the Corporation&#146;s products; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the Corporation&#146;s ability or plans to identify, develop, commercialize or expand its technology and research
and development initiatives in cannabinoids, or the success thereof; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">expectations regarding revenues, expenses and anticipated cash needs; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">expectations regarding cash flow, liquidity and sources of funding; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">expectations regarding capital expenditures; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the expansion of the Corporation&#146;s production and manufacturing, the costs and timing associated therewith
and the receipt of applicable production and sale licenses; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the expected growth in the Corporation&#146;s growing, production and supply chain capacities;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">expectations regarding the resolution of litigation and other legal proceedings; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">expectations with respect to future production costs; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">expectations with respect to future sales and distribution channels; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the expected methods to be used to distribute and sell the Corporation&#146;s products; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the Corporation&#146;s future product offerings; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the anticipated future gross margins of the Corporation&#146;s operations; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">accounting standards and estimates; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">expectations regarding the Corporation&#146;s distribution network; and </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">expectations regarding the costs and benefits associated with the Corporation&#146;s contracts and agreements
with third parties, including under the Corporation&#146;s third-party supply and manufacturing agreements. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Certain of
the forward-looking statements contained herein concerning the industries in which the Corporation conduct its business are based on estimates prepared by the Corporation using data from publicly available governmental sources, market research,
industry analysis and on assumptions based on data and knowledge of these industries, which the Corporation believes to be reasonable. However, although generally indicative of relative market positions, market shares and performance
characteristics, such data is inherently imprecise. The industries in which the Corporation conducts its business involve risks and uncertainties that are subject to change based on various factors, which are described further below. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The forward-looking statements contained herein are based upon certain material assumptions that were applied in drawing a conclusion or
making a forecast or projection, including: (i)&nbsp;management&#146;s perceptions of historical trends, current conditions and expected future developments; (ii)&nbsp;the Corporation&#146;s ability to generate cash flow from operations;
(iii)&nbsp;general economic, financial market, regulatory and political conditions in which the Corporation operates; (iv)&nbsp;the production and manufacturing capabilities and output from the Corporation&#146;s facilities and its joint ventures,
strategic alliances and equity investments; (v)&nbsp;consumer interest in the Corporation&#146;s products; (vi)&nbsp;competition; (vii) anticipated and unanticipated costs; (viii)&nbsp;government regulation of the Corporation&#146;s activities and
products including but not limited to the areas of taxation and environmental protection; (ix)&nbsp;the timely receipt of any required regulatory authorizations, approvals, consents, permits and/or licenses; (x)&nbsp;the Corporation&#146;s ability
to obtain qualified staff, equipment and services in a timely and cost-efficient manner; (xi)&nbsp;the Corporation&#146;s ability to conduct operations in a safe, efficient and effective manner; (xii)&nbsp;the Corporation&#146;s ability to realize
anticipated benefits, synergies or generate revenue, profits or value from its recent acquisitions into existing operations; (xiii)&nbsp;the Corporation&#146;s ability to continue to operate in light of the COVID-19 pandemic and the impact of the
pandemic on demand for, and sales of, the Corporation&#146;s products and its distribution channels; and (xiv)&nbsp;other considerations that management believes to be appropriate in the circumstances. While management considers these assumptions to
be reasonable based on information currently available to them, there is no assurance that such expectations will prove to be correct. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">By
their nature, forward-looking statements are subject to inherent risks and uncertainties that may be general or specific and which give rise to the possibility that expectations, forecasts, predictions, projections or conclusions will not prove to
be accurate, that assumptions may not be correct and that objectives, strategic goals and priorities will not be achieved. A variety of factors, including known and unknown risks, many of which are beyond the Corporation&#146;s control, could cause
actual results to differ materially from the <FONT STYLE="white-space:nowrap">forward-looking</FONT> statements in this prospectus and the documents incorporated or deemed to be incorporated by reference herein or made by the Corporation&#146;s
directors, officers, other employees and other persons authorized to speak on the Corporation&#146;s behalf. Such factors include, without limitation, changes in laws, regulations and guidelines and compliance with such laws, regulations and
guidelines; the risk that the <FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic may disrupt the Corporation&#146;s operations and those of its suppliers and distribution channels and negatively impact the use of the Corporation&#146;s
products; consumer demand for cannabis and U.S. hemp products; the Corporation&#146;s reliance on licenses issued by and contractual arrangements with various federal and provincial governmental authorities; future levels of revenues and the impact
of increasing levels of competition; the Corporation&#146;s ability to manage disruptions in credit markets or changes to its credit rating; future levels of capital, environmental or maintenance expenditures, general and administrative and other
expenses; the success or timing of completion of ongoing or anticipated capital or maintenance projects; business strategies, growth opportunities and expected investment; the adequacy of the Corporation&#146;s capital resources and liquidity,
including but not limited to, availability of sufficient cash flow to execute the Corporation&#146;s business plan (either within the expected timeframe or at all); the potential effects of judicial or other proceedings on the Corporation&#146;s
business, financial condition, results of operations and cash flows; volatility in and/or degradation of general economic, market, industry or business conditions; the Corporation&#146;s exposure to risks related to an agricultural business,
including wholesale price volatility and variable product quality; compliance with applicable environmental, economic, health and safety, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
energy and other policies and regulations and in particular health concerns with respect to vaping and the use of cannabis and U.S. hemp products in vaping devices; the anticipated effects of
actions of third parties such as competitors, activist investors or federal, state, provincial, territorial or local regulatory authorities, self-regulatory organizations, plaintiffs in litigation or persons threatening litigation; changes in
regulatory requirements in relation to the Corporation&#146;s business and products; and the factors discussed under the heading &#147;Risk Factors&#148; in the Annual Report on Form 10-K of the Corporation, as filed with the SEC on June 1, 2020.
Prospective investors are cautioned to consider these and other factors, uncertainties and potential events carefully and not to put undue reliance on <FONT STYLE="white-space:nowrap">forward-looking</FONT> statements. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Forward-looking statements are provided for the purposes of assisting prospective investors in understanding the Corporation&#146;s financial
performance, financial position and cash flows as of and for periods ended on certain dates and to present information about management&#146;s current expectations and plans relating to the future, and prospective investors are cautioned that the
forward-looking statements may not be appropriate for any other purpose. While the Corporation believes that the assumptions and expectations reflected in the <FONT STYLE="white-space:nowrap">forward-looking</FONT> statements are reasonable based on
information currently available to management, there is no assurance that such assumptions and expectations will prove to have been correct. Forward-looking statements are made as of the date they are made and are based on the beliefs, estimates,
expectations and opinions of management on that date. The Corporation undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, estimates or opinions, future events or results or otherwise
or to explain any material difference between subsequent actual events and such forward-looking statements, except as required by law. The forward-looking statements contained in this prospectus and the documents incorporated or deemed to be
incorporated by reference herein or made by the Corporation&#146;s directors, officers, other employees and other persons authorized to speak on the Corporation&#146;s behalf are expressly qualified in their entirety by these cautionary statements.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>You should read carefully the risk factors described in the documents incorporated by reference in this prospectus for a description
of certain risks that could, among other things, cause actual results to differ from these forward-looking statements.</B> </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx348413_4"></A>RISK FACTORS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">An investment in Securities of the Corporation is subject to certain risks, which should be carefully considered by prospective investors
before purchasing such Securities. In addition to the other information set out or incorporated by reference in this prospectus currently, and from time to time, investors should carefully consider the risk factors incorporated by reference in this
prospectus and referred to below. Any one of such risk factors could materially affect the Corporation&#146;s business, financial condition and/or future operating results and prospects and could cause actual events to differ materially from those
described in forward-looking statements and information relating to the Corporation. Additional risks and uncertainties not currently identified by the Corporation or that the Corporation currently believes not to be material also may materially and
adversely affect the Corporation&#146;s business, financial condition, operations or prospects. Investors should carefully consider the risks described under the heading &#147;Risk Factors&#148; in the Annual Report on Form <FONT
STYLE="white-space:nowrap">10-K</FONT> of the Corporation, as filed with the SEC on June&nbsp;1, 2020 (together with any material changes thereto contained in subsequently filed Quarterly Reports on Form 10-Q) and those contained in the
Corporation&#146;s other filings that are incorporated by reference in this prospectus and any accompanying prospectus supplement. See &#147;Documents Incorporated by Reference&#148;. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B>Risks Related to an Offering of Securities </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>No Assurance of Active or Liquid Market </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">No assurance can be given that an active or liquid trading market for the Common Shares will be sustained. If an active or liquid market for
the Common Shares fails to be sustained, the prices at which the Common Shares and other Securities trade may be adversely affected. Whether the Common Shares will trade at lower prices depends on many factors, including the liquidity of the Common
Shares, prevailing interest rates, the markets for similar securities, general economic conditions, the Corporation&#146;s financial condition, historic financial performance and future prospects. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">There is currently no market through which the Securities (other than the Common Shares) may be sold and purchasers may not be able to resell
such Securities. This may affect the pricing of such Securities in the secondary market, the transparency and availability of trading prices, the liquidity of such Securities and the extent of issuer regulation. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>Public Markets and Share Prices </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The market price of the Common Shares and any other Securities offered hereunder that become listed and posted for trading on the TSX, NASDAQ
or any other stock exchange could be subject to significant fluctuations in response to certain factors including, but not limited to, variations in the Corporation&#146;s operating results and changes in financial markets and general market
conditions, including those caused by <FONT STYLE="white-space:nowrap">COVID-19.</FONT> Securities markets have also experienced significant price and volume fluctuations from time to time. In some instances, these fluctuations have been unrelated
or disproportionate to the operating performance of issuers. Market fluctuations may adversely impact the market price of the Common Shares and any other Securities offered hereunder that become listed and posted for trading on the TSX, NASDAQ or
any other stock exchange. There can be no assurance of the price at which the Common Shares and any other Securities offered hereunder that become listed and posted for trading on the TSX, NASDAQ or any other stock exchange will trade. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>Additional Issuances and Dilution </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Corporation may issue and sell additional securities to finance its operations. The Corporation cannot predict the size or type of future
issuances of securities or the effect, if any, that future issuances and sales of securities will have on the market price of the Corporation&#146;s issued and outstanding securities from time to time. Sales or issuances of substantial amounts of
the Corporation&#146;s securities, or the perception that such sales could occur, may adversely affect prevailing market prices for the Corporation&#146;s issued and outstanding securities from </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
time to time. With any additional sale or issuance of the Corporation&#146;s securities, holders will suffer dilution with respect to voting power and may experience dilution in the
Corporation&#146;s earnings per share. Moreover, this prospectus may create a perceived risk of dilution resulting in downward pressure on the price of the issued and outstanding Common Shares, which could contribute to progressive declines in the
prices of such securities. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>Broad Discretion in the Use of the Net Proceeds </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Corporation&#146;s management will have broad discretion with respect to the application of net proceeds received by the Corporation from
the sale of Securities under this prospectus and may spend such proceeds in ways that do not improve the Corporation&#146;s results of operations or enhance the value of the Common Shares or the Corporation&#146;s other issued and outstanding
securities from time to time. Any failure by management to apply these funds effectively could result in financial losses that could have a material adverse effect on the Corporation&#146;s business or cause the price of the Corporation&#146;s
issued and outstanding securities to decline. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>History of Negative Cash Flow </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Corporation has a history of negative cash flow from operating activities. To the extent that the Corporation has negative cash flow in
future periods, the Corporation may need to allocate a portion of the net proceeds received from the sale of Securities hereunder or other financings to fund such negative cash flow. There can be no assurance that additional capital or other types
of financing will be available when needed or that these financings will be on terms at least as favourable to the Corporation as those previously obtained, or available to the Corporation or at all. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B>Risk of Infectious Diseases </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The outbreak of the novel coronavirus, or <FONT STYLE="white-space:nowrap">COVID-19,</FONT> which has been declared by the World Health
Organization (&#147;<B>WHO</B>&#148;) to be a &#147;pandemic&#148;, has spread across the globe and is impacting worldwide economic activity. <FONT STYLE="white-space:nowrap">COVID-19</FONT> has severely restricted the level of economic activity
around the world and in all countries in which the Corporation or its affiliates operate. For instance, economic activity in Alberta, one of the Corporation&#146;s key markets, has significantly declined due to the reduction in oil prices, a key
component of the Alberta economy, which has led to less discretionary consumer spending and lower spending on cannabis products. A public health epidemic, including COVID- 19, or the fear of a potential pandemic, poses the risk that the Corporation
or its employees, contractors, suppliers, and other partners may be prevented from conducting business activities for an indefinite period of time, and the Corporation&#146;s customers may be prevented from purchasing its products, due to shutdowns,
&#147;stay at home&#148; mandates or other preventative measures that may be requested or mandated by governmental authorities. The governments of many countries, states, cities and other geographic regions have taken such preventative or protective
actions, such as imposing restrictions on travel and business operations and advising or requiring individuals to limit or forego their time outside of their homes. Temporary closures of businesses have been ordered and numerous other businesses
have temporarily closed voluntarily. Such actions are creating disruption in global supply chains, increasing rates of unemployment and adversely impacting many industries. The outbreak could have a continued adverse impact on economic and market
conditions and trigger a period of global economic slowdown. Since a substantial portion of the Corporation&#146;s products not deemed to be necessities by the Corporation&#146;s customers, customers&#146; employment status and the amount of
customers&#146; discretionary spending and actual or perceived wealth can significantly impact the Corporation&#146;s results of operations. As a result, all of the <FONT STYLE="white-space:nowrap">above-described</FONT> factors (and other political
and economic factors) can have a material and adverse effect on spending patterns of the Corporation&#146;s customers and on the Corporation&#146;s business, financial condition and results of operations. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The effect of <FONT STYLE="white-space:nowrap">COVID-19</FONT> could include additional closures of the Corporation&#146;s facilities or the
facilities of the Corporation&#146;s suppliers and other vendors in the Corporation&#146;s supply chain and other preventive and protective measures in the Corporation&#146;s supply chain. If the pandemic persists, closures or other restrictions on
the conduct of business operations of the Corporation&#146;s <FONT STYLE="white-space:nowrap">third-party</FONT> manufacturers, suppliers or vendors could further disrupt the Corporation&#146;s supply chain. While the Corporation has not yet
experienced delays in shipping, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
the increased global demand on shipping and transport services may cause it to experience delays in the future, which could impact the Corporation&#146;s ability to obtain materials or deliver
its products in a timely manner. These factors could otherwise disrupt the Corporation&#146;s operations and could have an adverse effect on its business, financial condition and results of operations. In various jurisdictions in Canada, cannabis
retailers have been restricted to conducting sales via curbside pickup and online delivery or are reducing opening hours, staff onsite and reducing the number of customers allowed <FONT STYLE="white-space:nowrap">in-store</FONT> for cannabis
retailers that continue to be open. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Retailers of the Corporation&#146;s products in Canada and the United States have in some cases been
determined to be, and may in other cases be deemed in the future, <FONT STYLE="white-space:nowrap">non-essential</FONT> and be required to close or choose to suspend or significantly curtail their operations due to health and safety concerns for
their employees. Further, those retail operations that the Corporation has been able to reopen may be closed in the future in the event that governments reinstitute closures for public health reasons. Even if the Corporation&#146;s production
facilities remain open, mandatory or voluntary self- quarantines and travel restrictions may limit employees&#146; ability to get to the Corporation&#146;s facilities, and this, together with impacts on supply chain and the uncertainty produced by
the rapidly evolving nature of <FONT STYLE="white-space:nowrap">COVID-19,</FONT> may result in reduced or suspended production. Those types of restrictions could also impact the abilities of customers in certain Canadian jurisdictions or the United
States to continue to have access to the Corporation&#146;s products. Quarantines, shelter- <FONT STYLE="white-space:nowrap">in-place</FONT> and similar government orders, or the perception that such orders, shutdowns or other restrictions on the
conduct of business operations could occur, could impact personnel at third-party manufacturing facilities in Canada and the United States and other countries, or the availability or cost of materials, which would disrupt the Corporation&#146;s
supply chain, in particular in relation to the supply of masks, gowns and other protective equipment used at the Corporation&#146;s facilities due to the global shortage of such protective equipment and materials. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As a result of COVID-19, the Corporation has implemented <FONT STYLE="white-space:nowrap">work-from-home</FONT> policies for certain employees
and the effects of the <FONT STYLE="white-space:nowrap">work-from-home</FONT> policies may negatively impact productivity, disrupt access to books and records, increase cybersecurity risks and disrupt the Corporation&#146;s business, and the
Corporation does not yet know when it will be able to return to the office. In addition, the effects of COVID-19 may delay the Corporation&#146;s research and development programs and the Corporation&#146;s ability to execute on certain of its
strategic plans involving construction. So long as measures to combat <FONT STYLE="white-space:nowrap">COVID-19</FONT> stay in effect, the Corporation expects <FONT STYLE="white-space:nowrap">COVID-19</FONT> to negatively affect its results of
operations. The global impact of COVID-19 continues to evolve rapidly, and the extent of its effect on the Corporation&#146;s operational and financial performance will depend on future developments, which are highly uncertain, including the
duration, scope and severity of the pandemic, the actions taken to contain or mitigate its impact, and the direct and indirect economic effects of the pandemic and related containment measures, among others. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any positive impacts from preventive measures, vaccines or treatments for COVID-19 may be not be realized due to mutations in the COVID-19
virus, adverse side effects, difficulties in implementation or distribution or other factors, so there can be no assurance that such preventive measures, vaccines or treatments will have a material impact on the Corporation&#146;s business,
financial condition or results of operations. Furthermore, any &#147;second wave&#148; or mutated strains of COVID or the spread of other pathogens could also exacerbate the risks described in this risk factor. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Even after the pandemic subsides, the Corporation&#146;s businesses could also be negatively impacted should the effects of <FONT
STYLE="white-space:nowrap">COVID-19</FONT> lead to changes in consumer behavior, including as a result of a decline in discretionary spending. During the past year, financial conditions for the cannabis industry have faced increased volatility.
Moreover, future events could cause global financial conditions to suddenly and rapidly destabilize, and governmental authorities may have limited resources to respond to such future crises. Future crises may be precipitated by any number of causes,
including natural disasters, geopolitical instability, changes to energy prices or sovereign defaults. Any sudden or rapid destabilization of global economic conditions could negatively impact the Corporation&#146;s ability to obtain equity or debt
financing or make other suitable arrangements to finance its projects. If increased levels of volatility continue, there is a rapid destabilization of global economic conditions or a prolonged recession resulting from the pandemic, it would likely
materially affect the Corporation&#146;s business and the value of the Common Shares. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx348413_5"></A>CANOPY GROWTH CORPORATION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B>General </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Canopy Growth
was incorporated pursuant to the provisions of the <I>Canada Business Corporations Act </I>on August 5, 2009 under the name &#147;LW Capital Pool Inc.&#148; The Corporation changed its name to Tweed Marijuana Inc. on March 26, 2014, and later to
Canopy Growth Corporation on September 17, 2015. The Corporation&#146;s Common Shares are listed and posted for trading on the TSX under the symbol &#147;WEED&#148; and on NASDAQ under the symbol &#147;CGC&#148;. The Corporation maintains a website
at www.canopygrowth.com. Information on or connected to our website, even if referred to in documents incorporated by reference in this prospectus, does not constitute part of this prospectus. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Corporation&#146;s head and registered office is located at 1 Hershey Drive, Smiths Falls, Ontario, K7A 0A8. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B>Summary Description of the Business </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Canopy Growth is a world-leading diversified cannabis and cannabinoid-based consumer products company with operations in countries across the
world. Canopy Growth produces, distributes and sells a diverse range of cannabis and hemp-based products and other consumer products for both recreational and medical purposes under a portfolio of distinct brands in Canada pursuant to the Cannabis
Act, and globally pursuant to applicable international and Canadian legislation, regulations and permits. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On October 17, 2018, the
Cannabis Act came into effect in Canada, regulating both the medical and recreational cannabis markets in Canada and providing provincial, territorial and municipal governments the authority to prescribe regulations regarding the distribution and
sale of recreational cannabis. On October 17, 2019, the second phase of recreational cannabis products, specifically, ingestible cannabis, cannabis extracts and cannabis topical products (referred to as &#147;<B>Cannabis 2.0</B>&#148;), was
legalized pursuant to certain amendments to the regulations under the Cannabis Act. Canopy Growth currently offers product varieties in dried flower, oil, softgel capsule, vape pen power sources, pod-based vape devices, vape cartridges, <FONT
STYLE="white-space:nowrap">cannabis-infused</FONT> beverages and edibles, with product availability varying based on provincial and territorial regulations. Canopy Growth&#146;s recreational cannabis products are predominantly sold to provincial and
territorial agencies under a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">&#147;business-to-business&#148;</FONT></FONT> wholesale model, with those provincial and territorial agencies then being responsible for the distribution
of such products to brick-and-mortar stores and for online retail sales. Canopy Growth has also opened a network of Tweed and Tokyo Smoke retail cannabis stores across Canada, where permissible, to promote brand awareness and drive consumer demand
under a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">&#147;business-to-consumer&#148;</FONT></FONT> model. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Canopy
Growth&#146;s Spectrum Therapeutics medical division is a global leader in medical cannabis. Spectrum Therapeutics produces and distributes a diverse portfolio of medical cannabis products to healthcare practitioners and medical customers in Canada,
and in several other countries where it is federally permissible to do so. In April 2019, Canopy Growth acquired C3 Cannabinoid Compound Company, Europe&#146;s largest cannabinoid-based pharmaceuticals company and a leading manufacturer of
dronabinol, a registered active pharmaceutical ingredient in Germany and certain other European countries. The addition of dronabinol has allowed Canopy Growth to expand its portfolio of medical cannabis offerings for its customers in countries
where permissible. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subsequent to the passage of the U.S. Agricultural Improvement Act of 2018 in December 2018, Canopy Growth began
building its hemp supply chain in the United States through its investment in hemp growing capability and in processing, extraction and finished goods manufacturing facilities. In September 2020, Canopy Growth&#146;s Martha Stewart CBD line of
premium quality, hemp-derived wellness gummies, oils and softgels was launched in the United States. In the fourth quarter of fiscal 2021, Canopy Growth expanded its product offering to include CBD products for pets under the Martha Stewart CBD for
Pet line and SurityPro. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In June 2019, Canopy Growth implemented a plan of arrangement (the &#147;<B>Original Acreage
Arrangement</B>&#148;) pursuant to an arrangement agreement (the &#147;<B>Acreage Arrangement Agreement</B>&#148;) dated April&nbsp;18, 2019, as amended on May 15, 2019 with Acreage Holdings, Inc. (&#147;<B>Acreage</B>&#148;), a multi-state cannabis
operator. In September 2020, following receipt of all required approvals, Canopy Growth entered into a second amendment to the Acreage Arrangement Agreement (the &#147;<B>Amending Agreement</B>&#148;) and implemented an amended and restated plan of
arrangement (the &#147;<B>Acreage Amended Arrangement</B>&#148;). Pursuant to the Acreage Amended Arrangement, following the occurrence or waiver (at Canopy Growth&#146;s discretion) of changes in U.S. federal law to permit the general cultivation,
distribution, and possession of marijuana or to remove the regulation of such activities from the federal laws of the United States (the &#147;<B>Triggering Event</B>&#148;) and subject to the satisfaction or waiver of the conditions set out in the
Acreage Arrangement Agreement (as modified by the Amending Agreement), Canopy Growth (i)&nbsp;agreed to acquire approximately 70% of the issued and outstanding shares of Acreage, and (ii)&nbsp;obtained the right to acquire the other approximately
30% of the issued and outstanding shares of Acreage. The acquisition of Acreage, if completed, will provide a pathway into cannabis markets in the United States; however, Canopy Growth and Acreage will continue to operate as independent companies
until the acquisition of Acreage is completed. Refer to &#147;Recent Developments&#148; below for a description of the Acreage Amended Arrangement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Canopy Growth&#146;s other product offerings, which are sold by its subsidiaries in jurisdictions where it is permissible to do so, include
(i)&nbsp;Storz&nbsp;&amp; Bickel<SUP STYLE="font-size:85%; vertical-align:top">&#153;</SUP> vaporizers; (ii)&nbsp;thisworks<SUP STYLE="font-size:85%; vertical-align:top">&#153;</SUP> beauty, skincare, wellness and sleep products, some of which have
been blended with hemp-derived CBD isolate; (iii)&nbsp;BioSteel<SUP STYLE="font-size:85%; vertical-align:top">&#153;</SUP> sports nutrition beverages, mixes, protein, gum and mints, some of which have been infused with hemp-derived CBD isolate; and
(iv)&nbsp;a line of science-backed CBD products for dogs under the brand name SurityPro<SUP STYLE="font-size:85%; vertical-align:top">&#153;</SUP> sold by Canopy Animal Health. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The majority of Canopy Growth&#146;s products contain tetrahydrocannabinol (&#147;<B>THC</B>&#148;), CBD, or a combination of these two
cannabinoids which are found in the cannabis sativa plant species. THC is the primary psychoactive or intoxicating cannabinoid found in cannabis. References throughout this prospectus to &#147;hemp&#148; is used to classify varieties of the cannabis
sativa plant that contain CBD and 0.3% or less THC content (by dry weight). Conversely, references to the term &#147;marijuana&#148; refer to varieties of the cannabis sativa plant with more than 0.3% THC content and moderate levels of CBD. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Canopy Growth&#146;s licensed operational capacity in Canada includes indoor and greenhouse cultivation space; post-harvest processing and
cannabinoid extraction capability; advanced manufacturing capability for vape products, softgel encapsulation and <FONT STYLE="white-space:nowrap">pre-rolled</FONT> joints; a beverage production facility; a chocolate manufacturing facility; and a
gummie manufacturing facility. These infrastructure investments allow Canopy Growth to supply the recreational and medical markets with a complimentary balance of flower products and extracted cannabinoid input for Canopy Growth&#146;s oil, CBD and
Cannabis 2.0 products. Additionally, Canopy Growth has built a hemp supply chain in the United States and holds the necessary licenses to cultivate and produce cannabis in Denmark. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B>Recent Developments </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>Restructuring Actions and Sale of British Columbia Production Facilities </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In April 2020, Canopy Growth announced a series of global operational changes in order to optimize production, better align supply and demand
and improve efficiencies. As part of the strategic review of the business, the Corporation planned to (i)&nbsp;exit its operations in South Africa and Lesotho; (ii)&nbsp;close certain Canadian production facilities; (iii)&nbsp;shift its strategy in
Latin America; (iv)&nbsp;cease its hemp farming operations in Springfield, New York; and (v) rationalize certain marketing and research&nbsp;&amp; development activities. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In December 2020, as part of the ongoing <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">end-to-end</FONT></FONT> strategic
review of its operations, Canopy Growth announced a series of Canadian operational changes designed to streamline its operations and further improve gross margins. Canopy Growth has ceased operations at its sites in St. John&#146;s, Newfoundland and
Labrador; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Fredericton, New Brunswick; Edmonton, Alberta; Bowmanville, Ontario; as well as its outdoor cannabis grow operations in Saskatchewan. As a result of these restructuring actions, Canopy Growth
eliminated approximately 220 <FONT STYLE="white-space:nowrap">full-time</FONT> positions. Additionally, Canopy Growth (i)&nbsp;completed the sale of its production facilities in Aldergrove and Delta, British Columbia in December 2020 and January
2021, respectively, for combined proceeds of approximately US$40.7&nbsp;million; and (ii)&nbsp;completed its strategy shift in Latin America that was commenced in the fourth quarter of fiscal 2020. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>C$245 Million Warrant Exercise </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On May&nbsp;1, 2020, Greenstar Canada Investment Limited Partnership (&#147;<B>GCILP</B>&#148;) exercised 18,876,901 Common Share purchase
warrants at an exercise price of C$12.9783 per Common Share for aggregate proceeds to Canopy Growth of approximately C$245&nbsp;million. GCILP is a wholly-owned subsidiary of CBI. As a result of the acquisition of 18,876,901 Common Shares upon such
exercise, CBI now indirectly holds, in the aggregate, 142,253,802 Common Shares, 139,745,453 Common Share purchase warrants and C$200,000,000 principal amount of senior convertible notes. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>Acreage Amended Arrangement </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On June 24, 2020, Canopy Growth and Acreage entered into a proposal agreement (the &#147;<B>Acreage Proposal Agreement</B>&#148;) in order to,
among other things, implement the Acreage Amended Arrangement. In September 2020, Acreage obtained the requisite approvals of the shareholders of Acreage and the Supreme Court of British Columbia and on September 23, 2020, Canopy Growth and Acreage
entered into the Amending Agreement and implemented the Acreage Amended Arrangement. The Acreage Amended Arrangement provides for, among other things, the following: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">a capital reorganization of Acreage (the &#147;<B>Acreage Capital Reorganization</B>&#148;), pursuant to which
Acreage amended its Notice of Articles and Articles to, among other things, create the Acreage Fixed Shares (as defined below), the Acreage Floating Shares (as defined below) and the Acreage Fixed Multiple Shares (as defined below) and remove the
existing Acreage Class&nbsp;A subordinated voting shares (the &#147;<B>Acreage SVS</B>&#148;), the existing Acreage Class&nbsp;B proportionate voting shares (the &#147;<B>Acreage PVS</B>&#148;) and the existing Acreage Class&nbsp;C multiple voting
shares (the &#147;<B>Acreage MVS</B>&#148;). Pursuant to the Acreage Capital Reorganization (i)&nbsp;each outstanding Acreage SVS was exchanged for 0.7 of an Acreage Fixed Share and 0.3 of an Acreage Floating Share; (ii)&nbsp;each outstanding
Acreage PVS was exchanged for 28 Acreage Fixed Shares and 12 Acreage Floating Shares; and (iii)&nbsp;each outstanding Acreage MVS was exchanged for 0.7 of an Acreage Fixed Multiple Share and 0.3 of an Acreage Floating Share; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the new Class&nbsp;E subordinated voting shares (the &#147;<B>Acreage Fixed Shares</B>&#148;) have the same
attributes as the Acreage SVS and are listed on the Canadian Securities Exchange (the &#147;<B>CSE</B>&#148;). Following the occurrence or waiver (at the discretion of Canopy Growth) of the Triggering Event and subject to the satisfaction or waiver
of the conditions set out in the Acreage Arrangement Agreement (as modified by the Amending Agreement), Canopy Growth will acquire all of the issued and outstanding Acreage Fixed Shares based on an amended exchange ratio equal to 0.3048 of a Common
Share to be received for each Acreage Fixed Share held (reduced from 0.5818 per Acreage SVS pursuant to the Original Acreage Arrangement). The foregoing exchange ratio for the Acreage Fixed Shares is subject to adjustment in accordance with the
Acreage Amended Arrangement if, among other things, Acreage issues greater than the permitted number of Acreage Fixed Shares; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the new Class&nbsp;D subordinated voting shares (the &#147;<B>Acreage Floating Shares</B>&#148;) are listed on
the CSE. Upon the occurrence or waiver (at the discretion of Canopy Growth) of the Triggering Event and subject to the satisfaction or waiver of the conditions set out in the Acreage Arrangement Agreement (as modified by the Amending Agreement),
Canopy Growth will have the right exercisable for a period of 30 days thereafter, to acquire all of the issued and outstanding Acreage Floating Shares for cash or </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">
Common Shares or a combination thereof, in Canopy Growth&#146;s sole discretion, at a price equal to the 30-day volume weighted average trading price of the Acreage Floating Shares on the CSE,
subject to a minimum call price of US$6.41 per Acreage Floating Share. The foregoing exchange ratio for the Acreage Floating Shares is subject to adjustment in accordance with the Acreage Amended Arrangement if Acreage issues greater than the
permitted number of Acreage Floating Shares. The acquisition of the Acreage Floating Shares, if acquired, will take place concurrently with the closing of the acquisition of the Acreage Fixed Shares; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the new Class&nbsp;F multiple voting shares (the &#147;<B>Acreage Fixed Multiple Shares</B>&#148;) have the
same attributes as the Acreage MVS, provided that each Acreage Fixed Multiple Share entitles the holder thereof to 4,300 votes per Fixed Multiple Share at shareholder meetings of Acreage. Immediately prior to the acquisition of the Acreage Fixed
Shares, each issued and outstanding Acreage Fixed Multiple Share will automatically be exchanged for one Acreage Fixed Share and thereafter be acquired by Canopy Growth upon the same terms and conditions as the acquisition of the Acreage Fixed
Shares; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(e)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">if the occurrence or waiver of the Triggering Event does not occur within 10 years from the date the Acreage
Amended Arrangement was implemented (being September 23, 2030), Canopy Growth&#146;s rights to acquire both the Acreage Fixed Shares and the Acreage Floating Shares will terminate; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(f)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">upon implementation of the Acreage Amended Arrangement on September 23, 2020, Canopy Growth made a payment to
certain securityholders of Acreage of approximately US$37.5&nbsp;million; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(g)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Acreage is only permitted to issue an aggregate of up to 32,700,000 Acreage Fixed Shares and Acreage Floating
Shares. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In connection with the Acreage Amended Arrangement, an affiliate of the Corporation advanced US$50,000,000 to
Universal Hemp, LLC, a wholly-owned subsidiary of Acreage (&#147;<B>Acreage Hempco</B>&#148;) on September&nbsp;30, 2020 pursuant to a secured debenture (the &#147;<B>Debenture</B>&#148;). In accordance with the terms of the Debenture, the funds
cannot be used, directly or indirectly, in connection with or for any cannabis or cannabis-related operations in the United States, unless and until such operations comply with all applicable laws of the United States. The Debenture bears interest
at a rate of 6.1% per annum, matures 10 years from the implementation of the Acreage Amended Arrangement (being September&nbsp;23, 2030) or such earlier date in accordance with the terms of the Debenture, and all interest payments made pursuant to
the Debenture are payable in cash by Acreage Hempco. The Debenture is not convertible and is not guaranteed by Acreage. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>Addition of
Mr.&nbsp;Sabia to the Board of Directors </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In January 2020, Jim Sabia was appointed as a member of the board of directors (the
&#147;<B>Board</B>&#148;) of Canopy Growth, subject to completion of the standard Health Canada processes associated with his appointment to the Board. Pending completion of those processes, Mr.&nbsp;Sabia has acted as a Board observer. On September
4, 2020, Mr.&nbsp;Sabia received confirmation of security clearance from Health Canada and became a member of the Board. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>Listing on
NASDAQ </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In November 2020, Canopy Growth, acting pursuant to authorization from its Board, determined to voluntarily withdraw the
listing of the Common Shares from the New York Stock Exchange and transfer the listing to NASDAQ. Listing and trading of the Common Shares on NASDAQ commenced at market open on November 16, 2020. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>Rivers Arrangement Agreement </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On December&nbsp;21, 2020, Canopy Growth entered into an arrangement agreement (the &#147;<B>Rivers Arrangement Agreement</B>&#148;) with its <FONT
STYLE="white-space:nowrap">wholly-owned</FONT> subsidiary The Tweed Tree Lot Inc. (&#147;<B>Tweed NB</B>&#148;), RIV Capital Inc. (formerly Canopy Rivers Inc.) (&#147;<B>RIV Capital</B>&#148;) and its wholly-owned subsidiary RIV Capital Corporation
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
(formerly Canopy Rivers Corporation) (&#147;<B>RCC</B>&#148;), pursuant to which the Corporation will acquire certain assets from RCC, as set out below, in exchange for cash, Common Shares and
the surrender of all shares in the capital of RIV Capital held by Canopy Growth by way of a plan of arrangement under the <I>Business Corporations Act </I>(Ontario) (the &#147;<B>Rivers Arrangement</B>&#148;). The Rivers Arrangement was completed on
February&nbsp;23, 2021. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the Rivers Arrangement, Canopy Growth increased its conditional ownership interest in TerrAscend
Corp. (&#147;<B>TerrAscend</B>&#148;) through the acquisition of (i) 19,445,285 exchangeable shares in the capital of TerrAscend (the &#147;<B>TerrAscend Exchangeable Shares</B>&#148;) held by RCC; (ii) 2,225,714 common share purchase warrants in
the capital of TerrAscend with an exercise price of C$5.95 per share held by RCC; (iii) 333,723 common share purchase warrants in the capital of TerrAscend with an exercise price of C$6.49 per share held by RCC; and (iv)&nbsp;an approximately
C$13.2&nbsp;million loan receivable owing by TerrAscend Canada Inc. (&#147;<B>TerrAscend Canada</B>&#148;) to RCC. The securities in the capital of TerrAscend are not currently convertible or exercisable, and will not be convertible or exercisable
until federal laws in the United States with respect to marijuana are amended. Pursuant to the Rivers Arrangement, Canopy Growth also acquired (i)&nbsp;all of the Class&nbsp;A preferred shares in the capital of Les Serres Vert Cannabis Inc.
(&#147;<B>Vert Mirabel</B>&#148;) held by RCC; and (ii) 143 common shares in the capital of Vert Mirabel, thereby increasing Canopy Growth&#146;s ownership of the common shares of Vert Mirabel to approximately 55%. In addition, all of the
obligations of Tweed NB owing to RCC pursuant to a royalty agreement between the parties were terminated. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, all of the shares
of RIV Capital held by Canopy Growth were repurchased for cancellation on a cashless basis. Canopy Growth no longer has any equity, debt or other interest in RIV Capital following completion of the Rivers Arrangement. As additional consideration for
the assets transferred and the termination of the royalty agreement with Tweed NB, Canopy Growth made a cash payment to RCC of approximately C$115.0&nbsp;million and issued 3,647,902 Common Shares to RCC. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>TerrAscend Option Agreement </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On January 13, 2021, Canopy Growth entered into an option agreement (the &#147;<B>TerrAscend Option</B>&#148;) to acquire 1,072,450 common
shares of TerrAscend (the &#147;<B>TerrAscend Shares</B>&#148;) for approximately US$10.5&nbsp;million, conditional upon the occurrence or waiver of amendments to federal laws of the United States to permit the general cultivation, distribution and
possession of marijuana or to remove the regulation of such activities from the federal laws of the United States. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As of the date of this
prospectus, Canopy Growth owns 38,890,570 TerrAscend Exchangeable Shares, an aggregate of 22,474,130 TerrAscend Share purchase warrants and is deemed to own an aggregate of 1,072,450 TerrAscend Shares that are subject to the TerrAcend Option,
representing 100% of the issued and outstanding TerrAscend Exchangeable Shares on a <FONT STYLE="white-space:nowrap">non-diluted</FONT> basis and approximately 39.6% of the issued and outstanding TerrAscend Shares on a partially-diluted basis,
assuming the conversion of the TerrAscend Exchangeable Shares into TerrAscend Shares and the exercise of the TerrAscend Share purchase warrants and the TerrAscend Option held by Canopy Growth. Canopy Growth beneficially owns, and exercises control
or direction over approximately 20% of the issued and outstanding TerrAscend Shares on a fully-diluted basis. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>COVID-19 Pandemic
</I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Management has continued to closely monitor the impact of the <FONT STYLE="white-space:nowrap">COVID-19</FONT> global pandemic,
with a focus on the health and safety of the Corporation&#146;s employees, business continuity and supporting its communities. The Corporation established a <FONT STYLE="white-space:nowrap">COVID-19</FONT> Management Committee shortly after the
declaration of COVID-19 as a global pandemic and implemented various measures to reduce the spread of the virus. The Corporation has continued to operate under preventative measures and has experienced minimal disruption to its production and supply
chain. As of the date of this prospectus, all 33 of Canopy Growth&#146;s corporate-owned retail stores are open and offering <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">click-and-collect</FONT></FONT> and <FONT
STYLE="white-space:nowrap">in-</FONT> store shopping. Canopy Growth&#146;s Canadian medical business, which operates as an <FONT STYLE="white-space:nowrap">e-commerce</FONT> channel, has continued largely unchanged. Canopy Growth&#146;s
international medical </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
business operates primarily as a pharmacy model, with pharmacies being deemed essential businesses in Germany and other European countries in which Canopy Growth conducts business. In addition,
since Canopy Growth&#146;s <FONT STYLE="white-space:nowrap">non-production</FONT> workforce continues to effectively work remotely using various technology tools, Canopy Growth is able to maintain its full operations and internal controls over
financial reporting and disclosures. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Given the uncertainties associated with the <FONT STYLE="white-space:nowrap">COVID-19</FONT>
pandemic, including those related to the use of Canopy Growth&#146;s products by consumers, disruptions to the global and local economies due to related <FONT STYLE="white-space:nowrap">stay-at-home</FONT> orders, quarantine policies and
restrictions on travel, trade and business operations and a reduction in discretionary consumer spending, the Corporation is unable to estimate the impact of the COVID-19 pandemic on its business, financial condition, results of operations, and/or
cash flows. The uncertain nature of the impacts of the <FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic may continue to affect the Corporation&#146;s results of operations for the balance of fiscal 2021. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Canopy Growth believes it has sufficient liquidity available from cash and cash equivalents and short-term investments on hand of
approximately C$825.0&nbsp;million and C$768.6&nbsp;million, respectively, as of December&nbsp;31, 2020, and from available capacity under its revolving debt facility to enable Canopy Growth to meet its working capital and other operating
requirements, fund growth initiatives and capital expenditures, settle its liabilities, and repay scheduled principal and interest payments on debt. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx348413_6"></A>USE OF PROCEEDS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The net proceeds to Canopy Growth from any offering of Securities, the proposed use of those proceeds and the specific business objectives
that the Corporation expects to accomplish with such proceeds will be set forth in the applicable prospectus supplement relating to that offering of Securities. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">There may be circumstances where, on the basis of results obtained or for other sound business reasons, a
<FONT STYLE="white-space:nowrap">re-</FONT> allocation of funds may be necessary or prudent. Accordingly, management will have broad discretion in the application of the proceeds of an offering of Securities. The actual amount that the Corporation
spends in connection with each intended use of proceeds may vary significantly from the amounts specified in the applicable prospectus supplement and will depend on a number of factors, including those referred to under &#147;Risk Factors&#148; and
any other factors set forth in the applicable prospectus supplement. The Corporation may invest funds which it does not immediately use. Such investments may include short-term marketable investment grade securities. The Corporation may, from time
to time, issue securities (including debt securities) other than pursuant to this prospectus. See &#147;Risk Factors&#148;. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">During the
fiscal year ended March 31, 2020 and the nine-month period ended December&nbsp;31, 2020, the Corporation had negative cash flow from operating activities. To the extent that the Corporation has negative operating cash flows in future periods, the
Corporation may need to deploy a portion of its existing working capital to fund such negative cash flow. As at December&nbsp;31, 2020, the Corporation had cash and cash equivalents on hand of approximately C$825.0&nbsp;million and short-term
investments of approximately C$768.6&nbsp;million. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx348413_7"></A>DESCRIPTION OF SECURITIES </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B>Common Shares </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The
authorized share capital of the Corporation consists of an unlimited number of Common Shares. As of the close of business on the date prior to the date of this prospectus, there were an aggregate of 378,475,920 Common Shares issued and outstanding.
The Common Shares may be offered separately or together with other Securities, as the case may be. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Holders of Common Shares are entitled
to receive notice of any meetings of shareholders of the Corporation, to attend and to cast one vote per Common Share at all such meetings. Holders of Common Shares do not have cumulative voting rights with respect to the election of directors and,
accordingly, holders of a majority of the Common Shares entitled to vote in any election of directors may elect all directors standing for election. Holders of Common Shares are entitled to receive on a pro rata basis such dividends, if any, as and
when declared by the Corporation&#146;s Board of Directors at its discretion from funds legally available therefor and upon the liquidation, dissolution or winding up of the Corporation, are entitled to receive on a pro rata basis the net assets of
the Corporation after payment of debts and other liabilities, in each case subject to the rights, privileges, restrictions and conditions attaching to any other series or class of shares ranking senior in priority to or on a pro rata basis with the
holders of Common Shares with respect to dividends or liquidation. The Common Shares do not carry any pre- emptive, subscription, redemption or conversion rights, nor do they contain any sinking or purchase fund provisions. The Common Shares do not
carry any provisions permitting or restricting the issuance of additional securities or other material restrictions, nor do they contain any provisions requiring a securityholder to contribute additional capital. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B>Subscription Receipts </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following description sets forth certain general terms and provisions of Subscription Receipts that may be issued hereunder and is not
intended to be complete. Subscription Receipts may be issued at various times which will entitle holders thereof to receive, upon satisfaction of certain release conditions and for no additional consideration, Common Shares, Warrants, Units or any
combination thereof. The Subscription Receipts may be offered separately or together with other Securities, as the case may be. Subscription Receipts will be issued pursuant to one or more subscription receipt agreements (each, a
&#147;<B>Subscription Receipt Agreement</B>&#148;), each to be entered into between the Corporation and an escrow agent (the &#147;<B>Escrow Agent</B>&#148;) that will be named in the relevant prospectus supplement. Each Escrow Agent will be a
financial institution organized under the laws of Canada or a province thereof and authorized to carry on business as a trustee. If underwriters or agents are used in the sale of any Subscription Receipts, one or more of such underwriters or agents
may also be a party to the Subscription Receipt Agreement governing the Subscription Receipts sold to or through such underwriter or agent. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The statements made in this prospectus relating to any Subscription Receipt Agreement and Subscription Receipts to be issued under this
prospectus are summaries of certain anticipated provisions thereof and do not purport to be complete and are subject to, and are qualified in their entirety by reference to, the provisions of the applicable Subscription Receipt Agreement. You should
refer to the Subscription Receipt Agreement relating to the specific Subscription Receipts being offered for the complete terms of the Subscription Receipts. A copy of any Subscription Receipt Agreement relating to an offering or Subscription
Receipts will be filed by the Corporation with the securities regulatory authorities in applicable Canadian offering jurisdictions and the United States after the Corporation has entered into it. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The particular terms of each issue of Subscription Receipts will be described in the related prospectus supplement. This description may
include, but may not be limited to, any of the following, if applicable: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the designation and aggregate number of such Subscription Receipts being offered; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">18 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the price at which such Subscription Receipts will be offered; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the designation, number and terms of the Common Shares, Warrants, Units or any combination thereof to be received
by the holders of such Subscription Receipts upon satisfaction of the release conditions, and any procedures that will result in the adjustment of those numbers; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the conditions (the &#147;Release Conditions&#148;) that must be met in order for holders of such Subscription
Receipts to receive, for no additional consideration, Common Shares, Warrants, Units or any combination thereof; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the procedures for the issuance and delivery of the Common Shares, Warrants, Units or any combination thereof to
holders of such Subscription Receipts upon satisfaction of the Release Conditions; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">whether any payments will be made to holders of such Subscription Receipts upon delivery of the Common Shares,
Warrants, Units or any combination thereof upon satisfaction of the Release Conditions; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the identity of the Escrow Agent; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the terms and conditions under which the Escrow Agent will hold all or a portion of the gross proceeds from the
sale of such Subscription Receipts, together with interest and income earned thereon (collectively, the &#147;Escrowed Funds&#148;), pending satisfaction of the Release Conditions; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the terms and conditions under which the Escrow Agent will release all or a portion of the Escrowed Funds to the
Corporation upon satisfaction of the Release Conditions and if the Subscription Receipts are sold to or through underwriters or agents, the terms and conditions under which the Escrow Agent will release a portion of the Escrowed Funds to such
underwriters or agents in payment of all or a portion of their fees or commissions in connection with the sale of the Subscription Receipts; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">procedures for the refund by the Escrow Agent to holders of such Subscription Receipts of all or a portion of the
subscription price of their Subscription Receipts, plus any pro rata entitlement to interest earned or income generated on such amount, if the Release Conditions are not satisfied; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any contractual right of rescission to be granted to initial purchasers of such Subscription Receipts in the
event that this prospectus, the prospectus supplement under which Subscription Receipts are issued or any amendment hereto or thereto contains a misrepresentation; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any entitlement of the Corporation to purchase such Subscription Receipts in the open market by private agreement
or otherwise; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">if the Subscription Receipts are issued as a Unit with another Security, the date, if any, on and after which the
Subscription Receipts and the other Security will be separately transferable; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">whether the Corporation will issue such Subscription Receipts as global securities and, if so, the identity of
the depository for the global securities; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">whether the Corporation will issue such Subscription Receipts as bearer securities, as registered securities or
both; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">provisions as to modification, amendment or variation of the Subscription Receipt Agreement or any rights or
terms of such Subscription Receipts, including upon any subdivision, consolidation, reclassification or other material change of the Common Shares, Warrants, Units or other securities, any other reorganization, amalgamation, merger or sale of all or
substantially all of the Corporation&#146;s assets or any distribution of property or rights to all or substantially all of the holders of Common Shares; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">whether the Corporation will apply to list such Subscription Receipts on any exchange; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">19 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the material United States and Canadian federal income tax consequences of owning the Subscription Receipts; and
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any other material terms or conditions of such Subscription Receipts. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>Rights of Holders of Subscription Receipts Prior to Satisfaction of Release Conditions </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The holders of Subscription Receipts will not be, and will not have the rights of, shareholders of the Corporation. Holders of Subscription
Receipts are entitled only to receive Common Shares, Warrants, Units or a combination thereof on exchange or conversion of their Subscription Receipts, plus any cash payments, all as provided for under the Subscription Receipt Agreement and only
once the Release Conditions have been satisfied. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>Escrow </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Subscription Receipt Agreement will provide that the Escrowed Funds will be held in escrow by the Escrow Agent, and such Escrowed Funds
will be released to the Corporation (and, if the Subscription Receipts are sold to or through underwriters or agents, a portion of the Escrowed Funds may be released to such underwriters or agents in payment of all or a portion of their fees in
connection with the sale of the Subscription Receipts) at the time and under the terms specified by the Subscription Receipt Agreement. If the Release Conditions are not satisfied, holders of Subscription Receipts will receive a refund of all or a
portion of the subscription price for their Subscription Receipts, plus their pro-rata entitlement to interest earned or income generated on such amount, if provided for in the Subscription Receipt Agreement, in accordance with the terms of the
Subscription Receipt Agreement. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>Modifications </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Subscription Receipt Agreement will specify the terms upon which modifications and alterations to the Subscription Receipts issued
thereunder may be made by way of a resolution of holders of Subscription Receipts at a meeting of such holders or consent in writing from such holders. The number of holders of Subscription Receipts required to pass such a resolution or execute such
a written consent will be specified in the Subscription Receipt Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Subscription Receipt Agreement will also specify that the
Corporation may amend the Subscription Receipt Agreement and the Subscription Receipts, without the consent of the holders of the Subscription Receipts, to cure any ambiguity, to cure, correct or supplement any defective or inconsistent provision,
or in any other manner that will not materially and adversely affect the interests of the holder of outstanding Subscription Receipts or as otherwise specified in the Subscription Receipt Agreement. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B>Units </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following
description sets forth certain general terms and provisions of the Units that may be issued hereunder and is not intended to be complete. Units may be issued at various times comprising any combination of the other Securities described in this
prospectus. Each Unit will be issued so that the holder of such Unit is also the holder of each Security comprising such Unit. Therefore, the holder of a Unit will have the rights and obligations of a holder of each included Security (except in some
cases where the right to transfer an included Security of a Unit may not occur without the transfer of the other included Security comprising part of such Unit). The Units may be offered separately or together with other Securities, as the case may
be. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The particular terms of each issue of Units will be described in the related prospectus supplement. This description may include, but
may not be limited to, any of the following, if applicable: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the designation and aggregate number of Units; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">20 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the price at which the Units will be offered; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the designation and terms of the Units and the Securities comprising the Units, including whether and under what
circumstances those Securities may be held or transferred separately; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any provisions for the issuance, payment, settlement, transfer or exchange of the Units or of the Securities
comprising the Units; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">whether the Corporation will apply to list the Units on any exchange; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the material United States and Canadian federal income tax consequences of owning the Units, including how the
purchase price paid will be allocated among the Securities comprising the Units; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">whether the Units will be issued in fully registered or global form. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B>Warrants </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following
description sets forth certain general terms and provisions of Warrants for the purchase of Common Shares or Units that may be issued hereunder and is not intended to be complete. The Warrants may be offered separately or together with other
Securities, as the case may be. Warrants may be issued at various times under one or more warrant agreement to be entered into by the Corporation and one or more banks or trust companies acting as warrant agent. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The statements made in this prospectus relating to any warrant agreement and Warrants to be issued under this prospectus are summaries of
certain anticipated provisions thereof and do not purport to be complete and are subject to, and are qualified in their entirety by reference to, the provisions of the applicable warrant agreement. You should refer to the warrant agreement relating
to the specific Warrants being offered for the complete terms of the Warrants. A copy of any warrant agreement relating to an offering or Warrants will be filed by the Corporation with the securities regulatory authorities in applicable Canadian
offering jurisdictions and the United States after the Corporation has entered into it. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The particular terms of each issue of Warrants
will be described in the related prospectus supplement. This description may include, but may not be limited to, any of the following, if applicable: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the designation and aggregate number of Warrants; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the price at which the Warrants will be offered; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the designation, number and terms of the Common Shares or Units, as applicable, purchasable upon exercise of the
Warrants, and procedures that will result in the adjustment of those numbers; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the date on which the right to exercise the Warrants will commence and the date on which such right will expire;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the exercise price of the Warrants; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">if the Warrants are issued as a Unit with another Security, the date, if any, on and after which the Warrants and
the other Security will be separately transferable; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any minimum or maximum amount of Warrants that may be exercised at any one time; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any terms, procedures and limitations relating to the transferability, exchange or exercise of the Warrants;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">whether the Warrants will be subject to redemption or call and, if so, the terms of such redemption or call
provisions; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">provisions as to modification, amendment or variation of the warrant agreement or any rights or terms of such
Warrants, including upon any subdivision, consolidation, reclassification or other material </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">21 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">
change of the Common Shares, Units or other securities, any other reorganization, amalgamation, merger or sale of all or substantially all of the Corporation&#146;s assets or any distribution of
property or rights to all or substantially all of the holders of Common Shares; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the material United States and Canadian federal income tax consequences of owning the Warrants; and
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any other material terms or conditions of the Warrants. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Warrant certificates will be exchangeable for new Warrant certificates of different denominations at the office indicated in the prospectus
supplement. Prior to the exercise of their Warrants, holders of Warrants will not have any of the rights of holders of the securities subject to the Warrants. The Corporation may amend the warrant agreement(s) and the Warrants, without the consent
of the holders of the Warrants, to cure any ambiguity, to cure, correct or supplement any defective or inconsistent provision or in any other manner that will not prejudice the rights of the holders of outstanding Warrants, as a group. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">22 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx348413_8"></A>CERTAIN INCOME TAX CONSIDERATIONS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The applicable prospectus supplement will describe certain U.S. federal income tax consequences of the acquisition, ownership and disposition
of any Securities offered thereunder by an initial investor who is a U.S. person (within the meaning of the U.S. Internal Revenue Code). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The applicable prospectus supplement will also describe certain Canadian federal income tax consequences to an investor, including investors
who are <FONT STYLE="white-space:nowrap">non-residents</FONT> of Canada, of acquiring, owning and disposing any Securities offered thereunder. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx348413_9"></A>SELLING SECURITYHOLDERS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Information about selling securityholders, where applicable, will be set forth in a prospectus supplement, in a post- effective amendment or
in filings we make with the SEC under the Exchange Act which are incorporated by reference into this prospectus. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">23 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx348413_10"></A>PLAN OF DISTRIBUTION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Corporation may offer and sell the Securities on a continuous or delayed basis, separately or together: (a)&nbsp;to one or more
underwriters or dealers; (b)&nbsp;through one or more agents; or (c)&nbsp;directly to one or more other purchasers. The Securities offered pursuant to any prospectus supplement may be sold from time to time in one or more transactions at: (i)&nbsp;a
fixed price or prices, which may be changed from time to time; (ii)&nbsp;market prices prevailing at the time of sale; (iii)&nbsp;prices related to such prevailing market prices; or (iv)&nbsp;other negotiated prices, including in transactions that
are deemed to be <FONT STYLE="white-space:nowrap">&#147;at-the-market</FONT> distributions,&#148; including sales made directly on the TSX, NASDAQ or other existing trading markets for the Securities. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A description of such price will be disclosed in the applicable prospectus supplement. The prices at which the Securities may be offered may
vary as between purchaser and during the period of distribution. If, in connection with the offering of Securities at a fixed price or prices, the underwriters have made a bona fide effort to sell all of the Securities at the initial offering price
fixed in the applicable prospectus supplement, the public offering price may be decreased and thereafter further changed, from time to time, to an amount not greater than the initial public offering price fixed in such prospectus supplement, in
which case the compensation realized by the underwriters will be decreased by the amount that the aggregate price paid by purchasers for the Securities is less than the gross proceeds paid by the underwriters to the Corporation. The Corporation will
obtain any requisite exemptive relief prior to conducting <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">&#147;at-the-market</FONT></FONT> distributions&#148;. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each prospectus supplement will set forth the terms of the offering, including the type of Security being offered, the name or names of any
underwriters, dealers or agents, the purchase price of such Securities, the proceeds to the Corporation from such sale, any underwriting commissions or discounts and other items constituting underwriters&#146; compensation and any discounts or
concessions allowed or <FONT STYLE="white-space:nowrap">re-allowed</FONT> or paid to dealers. Only underwriters so named in the prospectus supplement are deemed to be underwriters in connection with the Securities offered thereby. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>By Underwriters </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If underwriters are used in the sale of Securities under this prospectus and any prospectus supplement, the Securities will be acquired by the
underwriters for their own account and may be resold from time to time in one or more transactions, including negotiated transactions, at a fixed public offering price or at varying prices determined at the time of sale. Unless otherwise set forth
in the prospectus supplement relating thereto, the obligations of underwriters to purchase the Securities will be subject to certain conditions, but the underwriters will be obligated to purchase all of the Securities offered by the prospectus
supplement if any of such Securities are purchased. The Corporation may agree to pay the underwriters a fee or commission for various services relating to the offering of any Securities. Any such fee or commission will be paid out of the proceeds of
the offering or the general corporate funds of the Corporation. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>By Dealers </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If dealers are used, and if so specified in the applicable prospectus supplement, the Corporation will sell such Securities to the dealers as
principals. The dealers may then resell such Securities to the public at varying prices to be determined by such dealers at the time of resale. Any public offering price and any discounts or concessions allowed or
<FONT STYLE="white-space:nowrap">re-</FONT> allowed or paid to dealers may be changed from time to time. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>By Agents </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Securities may also be sold through agents designated by the Corporation. Any agent involved will be named, and any fees or commissions
payable by the Corporation to such agent will be set forth, in the applicable prospectus supplement. Any such fees or commissions will be paid out of the proceeds of the offering or the general corporate funds of the Corporation. Unless otherwise
indicated in the prospectus supplement, any agent will be acting on a best efforts basis for the period of its appointment. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">24 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>Direct Sales </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Securities may also be sold directly by the Corporation at such prices and upon such terms as agreed to by the Corporation and the purchaser.
In this case, no underwriters, dealers or agents would be involved in the offering. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>General Information </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Underwriters, dealers and agents that participate in the distribution of the Securities offered by this prospectus may be deemed underwriters
under the Securities Act, and any discounts or commissions they receive from the Corporation and any profit on their resale of the securities may be treated as underwriting discounts and commissions under the Securities Act. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Underwriters, dealers or agents who participate in the distribution of Securities may be entitled under agreements to be entered into with the
Corporation to indemnification by the Corporation against certain liabilities, including liabilities under Canadian provincial and territorial and United States securities legislation, or to contribution with respect to payments which such
underwriters, dealers or agents may be required to make in respect thereof. Such underwriters, dealers or agents may be customers of, engage in transactions with, or perform services for, the Corporation in the ordinary course of business. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Corporation may enter into derivative transactions with third parties, or sell securities not covered by this prospectus to third parties
in privately negotiated transactions. If the applicable prospectus supplement indicates, in connection with those derivatives, the third parties may sell securities covered by this prospectus and the applicable prospectus supplement, including in
short sale transactions. If so, the third parties may use securities pledged by the Corporation or borrowed from the Corporation or others to settle those sales or to close out any related open borrowings of securities and may use securities
received from the Corporation in settlement of those derivatives to close out any related open borrowings of securities. The third parties in such sale transactions will be identified in the applicable prospectus supplement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">One or more firms, referred to as &#147;remarketing firms,&#148; may also offer or sell the Securities, if the prospectus supplement so
indicates, in connection with a remarketing arrangement upon their purchase. Remarketing firms will act as principals for their own accounts or as agents for the Corporation. These remarketing firms will offer or sell the Securities in accordance
with the terms of the Securities. The prospectus supplement will identify any remarketing firm and the terms of its agreement, if any, with the Corporation and will describe the remarketing firm&#146;s compensation. Remarketing firms may be deemed
to be underwriters in connection with the Securities they remarket. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In connection with any offering of Securities (unless otherwise
specified in the prospectus supplement), the underwriters may <FONT STYLE="white-space:nowrap">over-allot</FONT> or effect transactions which stabilize or maintain the market price of the Securities offered at a level above that which might
otherwise prevail in the open market. Such transactions may be commenced, interrupted or discontinued at any time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Agents, underwriters
or dealers may make sales of Securities in privately negotiated transactions and/or any other method permitted by law, including sales deemed to be an
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">&#147;at-the-market</FONT></FONT> distribution&#148; and subject to limitations imposed by and the terms of any regulatory approvals required and obtained under, applicable Canadian
securities laws which includes sales made directly on an existing trading market for the Common Shares, or sales made to or through a market maker other than on a securities exchange. In connection with any offering of Securities, except with
respect to <FONT STYLE="white-space:nowrap">&#147;at-the-market</FONT> distributions&#148;, underwriters may <FONT STYLE="white-space:nowrap">over-allot</FONT> or effect transactions which stabilize or maintain the market price of the offered
Securities at a level above that which might otherwise prevail in the open market. Such transactions may be commenced, interrupted or discontinued at any time. No underwriter or dealer involved in an &#147;at-the-market distribution&#148;, no
affiliate of such an underwriter or dealer and no person or company acting jointly or in concert with such an underwriter or dealer will over-allot Securities in connection with such distribution or effect any other transactions that are intended to
stabilize or maintain the market price of the Securities. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">25 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Corporation may authorize agents or underwriters to solicit offers by eligible
institutions to purchase Securities at the public offering price set forth in the applicable prospectus supplement under delayed delivery contracts providing for payment and delivery on a specified date in the future. The conditions to these
contracts and the commissions payable for solicitation of these contracts will be set forth in the applicable prospectus supplement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each
class of Securities, other than the Common Shares, will be a new issue of Securities with no established trading market. Subject to applicable laws, any underwriter may make a market in such Securities, but will not be obligated to do so and may
discontinue any market making at any time without notice. There may be limited liquidity in the trading market for any such Securities. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unless otherwise specified in the applicable prospectus supplement, the Corporation does not intend to list any of the Securities other than
the Common Shares on any securities exchange. Consequently, unless otherwise specified in the applicable prospectus supplement, there is no market through which the Subscription Receipts, Units and Warrants may be sold and purchasers may not be able
to resell any such Securities purchased under this prospectus. This may affect the pricing of the Subscription Receipts, Units and Warrants in the secondary market, the transparency and availability of trading prices, the liquidity of such
Securities and the extent of issuer regulation. No assurances can be given that a market for trading in Securities of any series or issues will develop or as to the liquidity of any such market, whether or not the Securities are listed on a
securities exchange. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>Participation Rights and Registration Rights </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Corporation is party to a second amended and restated investor rights agreement (the &#147;<B>Investor Rights Agreement</B>&#148;) with
GCILP and CBG Holdings LLC (collectively, the &#147;<B>CBG Group</B>&#148;) dated April&nbsp;18, 2019. The Investor Rights Agreement provides that the CBG Group will be entitled to certain <FONT STYLE="white-space:nowrap">pre-emptive</FONT> and
top-up rights in connection with the issuance of further securities by Canopy Growth so as to permit the CBG Group to maintain its percentage in the issued and outstanding Common Shares and the Original Percentage or the Percentage of Outstanding
Common Shares (each as defined in the Investor Rights Agreement), as the case may be, for so long as the CBG Group holds the Target Number of Shares (as defined in the Investor Rights Agreement) and the Investor Rights Agreement has not been
terminated. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, to the <FONT STYLE="white-space:nowrap">pre-emptive</FONT> and top-up rights, the Investor Rights Agreement
provides the CBG Group with certain rights to require Canopy Growth to qualify for distribution in Canada or the United States under a prospectus (or the equivalent document in jurisdictions outside of Canada) the sale of Common Shares by the CBG
Group and/or its affiliates or designees during the term of the Investor Rights Agreement. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>Certain United States Matters
</I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any Securities initially sold outside the United States may be resold in the United States through underwriters, dealers or
otherwise. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">To comply with the securities laws of some states of the United States, if applicable, the Securities may be sold in these
jurisdictions only through registered or licensed brokers or dealers. In addition, in some states of the United States the Securities may not be sold unless they have been registered or qualified for sale or an exemption from registration or
qualification requirements is available and is complied with. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">26 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx348413_11"></A>LEGAL MATTERS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The validity of the Common Shares, Subscription Receipts, Units and Warrants offered hereby and certain other Canadian legal matters related
to the Securities being offered hereby will be passed upon for us by Cassels Brock&nbsp;&amp; Blackwell LLP. Certain US matters in connection with certain offerings under this base prospectus will be passed upon for the issuers by Paul, Weiss,
Rifkind, Wharton&amp; Garrison LLP. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx348413_12"></A>EXPERTS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The consolidated financial statements of Canopy Growth Corporation as of March 31, 2020 and 2019, and for each of the years in the three-year
period ended March&nbsp;31, 2020, and management&#146;s assessment of the effectiveness of internal control over financial reporting as of March 31, 2020, have been incorporated by reference herein in reliance on the reports of KPMG LLP, independent
public accounting firm, incorporated by reference herein, and upon the authority of said firm as experts in auditing and accounting. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx348413_13">
</A>ENFORCEABILITY OF CIVIL LIABILITIES </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are a corporation incorporated under and governed by the CBCA. Some of our officers and
directors, and some of the experts named in this prospectus, are Canadian residents, and many of our assets or the assets of our officers and directors and the experts are located outside the United States. We have appointed an agent for service of
process in the United States, but it may be difficult for holders of Securities who reside in the United States to effect service within the United States upon those directors, officers and experts who are not residents of the United States. It may
also be difficult for holders of Securities who reside in the United States to realize in the United States upon judgments of courts of the United States predicated upon our civil liability and the civil liability of our officers and directors and
experts under the United States federal securities laws. We have been advised by our Canadian counsel, Cassels Brock&nbsp;&amp; Blackwell LLP, that a judgment of a United States court predicated solely upon civil liability under U.S. federal
securities laws could be enforceable in Canada if the United States court in which the judgment was obtained has a basis for jurisdiction in the matter that would be recognized by a Canadian court for the same purposes. We have also been advised by
Cassels Brock&nbsp;&amp; Blackwell LLP, however, that there is substantial doubt whether an action could be brought in Canada in the first instance on the basis of liability predicated solely upon U.S. federal securities laws. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">27 </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-FILING FEES
<SEQUENCE>2
<FILENAME>d348413dexfilingfees.htm
<DESCRIPTION>EX-FILING FEES
<TEXT>
<HTML><HEAD>
<TITLE>EX-FILING FEES</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 107 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Calculation of Filing Fee Table </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>424b7</B> </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Form Type) </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Canopy Growth Corporation</B> </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Exact Name of Registrant as Specified in its Charter) </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>Table 1: Newly Registered Securities </U></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="96%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="41%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="1" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; padding-left:8pt">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="4" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="4" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="4" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="4" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="4" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="4" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8pt">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="padding-bottom:1pt ;"><B>Security<BR>Type</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:1pt ;"><B>Security<BR>Class&nbsp;Title</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:1pt ;"><B>Fee<BR>Calculation<BR>Rule</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="padding-bottom:1pt ;"><B>Amount<BR>Registered<SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="padding-bottom:1pt ;"><B>Proposed<BR>Maximum<BR>Offering<BR>Price Per<BR>Unit <SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="padding-bottom:1pt ;"><B>Maximum<BR>Aggregate Offering<BR>Price<SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="padding-bottom:1pt ;"><B>Fee Rate</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="padding-bottom:1pt ;"><B>Amount of<BR>Registration<BR>Fee</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-RIGHT:1px solid #000000; padding-right:2pt">&nbsp;</TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER:1px solid #000000; padding-left:8pt"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Fees to Be Paid</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top" STYLE="BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD NOWRAP VALIGN="top" STYLE="BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000" ALIGN="right">Equity</TD>
<TD NOWRAP VALIGN="top" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="top" NOWRAP ALIGN="center" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">Common<BR>Shares,&nbsp;no<BR>par value</TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="top" NOWRAP ALIGN="center" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">457(c)<BR>
<P STYLE="margin-bottom:1pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">457(r)</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD NOWRAP VALIGN="top" STYLE="BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD NOWRAP VALIGN="top" STYLE="BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000" ALIGN="right">4,257,129</TD>
<TD NOWRAP VALIGN="top" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top" STYLE="BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000">$</TD>
<TD NOWRAP VALIGN="top" STYLE="BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000" ALIGN="right">5.175</TD>
<TD NOWRAP VALIGN="top" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top" STYLE="BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000">$</TD>
<TD NOWRAP VALIGN="top" STYLE="BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000" ALIGN="right">22,030,642.58</TD>
<TD NOWRAP VALIGN="top" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top" STYLE="BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD NOWRAP VALIGN="top" STYLE="BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000" ALIGN="right">0.0000927</TD>
<TD NOWRAP VALIGN="top" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top" STYLE="BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000">$</TD>
<TD NOWRAP VALIGN="top" STYLE="BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000" ALIGN="right">2,042.25</TD>
<TD NOWRAP VALIGN="top" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:2pt"><SUP STYLE="font-size:85%; vertical-align:top">(3)</SUP>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER:1px solid #000000; padding-left:8pt">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP STYLE="BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" COLSPAN="13" NOWRAP STYLE="BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><B>Total Offering Amounts</B></TD>
<TD VALIGN="bottom" NOWRAP STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><B>$</B></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000" ALIGN="right"><B>22,030,642.58</B></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><B>$</B></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000" ALIGN="right"><B>2,042.25</B></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:2pt"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="1" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; padding-left:8pt">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="16" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="4" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="4" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="4" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; padding-left:8pt">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP STYLE="padding-bottom:1pt ;"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" COLSPAN="13" NOWRAP STYLE="padding-bottom:1pt ;"><B>Total Fees Previously Paid</B></TD>
<TD VALIGN="bottom" NOWRAP STYLE="padding-bottom:1pt ;"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:1pt ;">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:1pt ;" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:1pt ;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:1pt ;">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:1pt ;" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:1pt ;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:1pt ;">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:1pt ;" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:1pt ;BORDER-RIGHT:1px solid #000000; padding-right:2pt">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="1" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; padding-left:8pt">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="16" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="4" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="4" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="4" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; padding-left:8pt">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP STYLE="padding-bottom:1pt ;"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" COLSPAN="13" NOWRAP STYLE="padding-bottom:1pt ;"><B>Total Fee Offsets</B></TD>
<TD VALIGN="bottom" NOWRAP STYLE="padding-bottom:1pt ;"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:1pt ;">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:1pt ;" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:1pt ;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:1pt ;">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:1pt ;" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:1pt ;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:1pt ;">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:1pt ;" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:1pt ;BORDER-RIGHT:1px solid #000000; padding-right:2pt">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="1" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; padding-left:8pt">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="16" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="4" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="4" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="4" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8pt">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP STYLE="padding-bottom:1pt ;BORDER-BOTTOM:1px solid #000000"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" COLSPAN="13" NOWRAP STYLE="padding-bottom:1pt ;BORDER-BOTTOM:1px solid #000000"><B>Net Fee Due</B></TD>
<TD VALIGN="bottom" NOWRAP STYLE="padding-bottom:1pt ;BORDER-BOTTOM:1px solid #000000"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:1pt ;BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:1pt ;BORDER-BOTTOM:1px solid #000000" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:1pt ;BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:1pt ;BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:1pt ;BORDER-BOTTOM:1px solid #000000" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:1pt ;BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:1pt ;BORDER-BOTTOM:1px solid #000000"><B>$</B></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:1pt ;BORDER-BOTTOM:1px solid #000000" ALIGN="right"><B>2,042.25</B></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:1pt ;BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:2pt"><B>&nbsp;</B></TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Consists of a maximum of 4,257,129 common shares to be sold by the selling securityholders. Pursuant to Rule
416(a) of the Securities Act of 1933, as amended (the &#147;Securities Act&#148;), this Registration Statement shall also cover any additional shares of the Registrant&#146;s Common Shares (&#147;Common Shares&#148;) in connection with any stock
dividend, stock split, recapitalization or other similar transaction effected without receipt of consideration that increases the number of outstanding shares of Common Stock. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Estimated solely for the purpose of calculating the amount of the registration fee pursuant to Rule 457(c) of
the Securities Act. The proposed maximum offering price per share and the proposed maximum aggregate offering price with respect to the shares are calculated based on $5.175 per share, the average of the high and low prices of the Common Shares, as
reported on the Nasdaq Capital Market on May&nbsp;12, 2022. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The registration fee is calculated in accordance with Rule 457(r) of the Securities Act and represents deferred
payment of the registration fees in connection with the registrant&#146;s Registration Statement on Form <FONT STYLE="white-space:nowrap">S-3ASR</FONT> (Registration <FONT STYLE="white-space:nowrap">No.&nbsp;333-253399)</FONT> paid with the filing
of this prospectus supplement. </P></TD></TR></TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD></TR>
</TABLE>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g348413g02v02.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g348413g02v02.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[2N^4&AO=&]S:&]P(#,N,  X0DE-! 0
M    *Z*^$1<#A"24T$!       0!P!6@ #&R5'' (   +[.AP"4  (<G(R,#
M8P,S0< @4 'TUI8W)O<V]F="!7;W)D("T@0T=#7U!R;W-P96-T=7,X0DE-!"
M4      ! :5R60Z>1 V5 ?<BJBEW;T.$))300Z      #E    $     $
M    MP<FEN=$]U='!U=     4     4'-T4V)O;VP!     $EN=&5E;G5M
M   $EN=&4     0VQR;0    ]P<FEN=%-I>'1E96Y":71B;V]L      MP<F
MEN=&5R3F%M951%6%0    !       /<')I;G10<F]O9E-E='5P3V)J8P
MP 4 !R &\ ;P!F "  4P!E '0 =0!P       *<')O;V93971U<     $
M  0FQT;F5N=6T    ,8G5I;'1I;E!R;V]F    "7!R;V]F0TU92P X0DE-!#
ML      BT    0     0      $G!R:6YT3W5T<'5T3W!T:6]N<P   !<
M  0W!T;F)O;VP      $-L8G)B;V]L      !29W--8F]O;       0W)N0V
M)O;VP      $-N=$-B;V]L      !,8FQS8F]O;       3F=T=F)O;VP
M   $5M;$1B;V]L      !);G1R8F]O;       0F-K9T]B:F,    !
M  4D="0P    ,     4F0@(&1O=6) ;^            !'<FX@9&]U8D!OX
M           $)L("!D;W5B0&_@            0G)D5%5N=$8C4FQT
M          0FQD(%5N=$8C4FQT                4G-L=%5N=$8C4'AL0%
M?^H(         *=F5C=&]R1&%T86)O;VP!     %!G4'-E;G5M     %!G4'
M,     4&=00P    !,969T56YT1B-2;'0               !4;W @56YT1B
M-2;'0               !38VP@56YT1B-0<F- 60           !!C<F]P5V
MAE;E!R:6YT:6YG8F]O;      .8W)O<%)E8W1";W1T;VUL;VYG
MQC<F]P4F5C=$QE9G1L;VYG          UC<F]P4F5C=%)I9VAT;&]N9P
M     +8W)O<%)E8W14;W!L;VYG       X0DE- ^T      !  7_J"  $  @
M!?^H(  0 ".$))300F       .             #^    X0DE-! T
M0   !X.$))3009       $    'CA"24T#\P      "0           0 X0D
ME-)Q        H  0         ".$))30/U      !( "]F9@ ! &QF9@ &
M     ! "]F9@ ! *&9F@ &       ! #(    ! %H    &       ! #4
M ! "T    &       !.$))30/X      !P  #_______________________
M______ ^@     _____________________________P/H     /________
M____________________\#Z     #_____________________________ ^
M@  #A"24T$"       $     $   )    "0      X0DE-!!X       0
M  .$))300:      ,U    !@              IP   0@          0
M                     !              $(    IP
M     !                         !     !        ;G5L;     (
M &8F]U;F1S3V)J8P    $       !28W0Q    !     !4;W @;&]N9P
M      3&5F=&QO;F<          $)T;VUL;VYG    IP    !29VAT;&]N9P
M   0@    &<VQI8V5S5FQ,<P    %/8FIC     0      !7-L:6-E    $@
M    =S;&EC94E$;&]N9P         '9W)O=7!)1&QO;F<         !F]R:6
M=I;F5N=6T    ,15-L:6-E3W)I9VEN    #6%U=&]'96YE<F%T960     5'
MEP965N=6T    *15-L:6-E5'EP90    !);6<@    !F)O=6YD<T]B:F,
M !        4F-T,0    0     5&]P(&QO;F<          $QE9G1L;VYG
M        !"=&]M;&]N9P   *<     4F=H=&QO;F<   $(     W5R;%1%6%
M0    !        ;G5L;%1%6%0    !        37-G951%6%0    !
M &86QT5&%G5$585     $       YC96QL5&5X=$ES2%1-3&)O;VP!    "&
M-E;&Q497AT5$585     $       EH;W)Z06QI9VYE;G5M    #T53;&EC94
MAO<GI!;&EG;@    =D969A=6QT    "79E<G1!;&EG;F5N=6T    /15-L:6
M-E5F5R=$%L:6=N    !V1E9F%U;'0    +8F=#;VQO<E1Y<&5E;G5M    $4
M53;&EC94)'0V]L;W)4>7!E     $YO;F4    )=&]P3W5T<V5T;&]N9P
M     *;&5F=$]U='-E=&QO;F<         #&)O='1O;4]U='-E=&QO;F<
M      "W)I9VAT3W5T<V5T;&]N9P      .$))300H       ,     C_P
M      .$))3001       ! 0 X0DE-!!0       0    #.$))300,     "
M%#     0   *    !E   !X   O6   "$G !@  ?_8_^(,6$E#0U]04D]&24
MQ%  $!   ,2$QI;F\"$   ;6YT<E)'0B!865H@!\X  @ )  8 ,0  86-S<$
MU31E0     245#('-21T(               $  /;6  $     TRU(4" @
M
M 18W!R=    5     S9&5S8P   80   !L=W1P=    ?     48FMP=    @
M0    4<EA96@   A@    49UA96@   BP    48EA96@   D     49&UN9
M   E0   !P9&UD9    L0   "(=G5E9    TP   "&=FEE=P   ]0    D;'
M5M:0   _@    4;65A<P  ! P    D=&5C:   !#     ,<E120P  !#P
M@,9U120P  !#P   @,8E120P  !#P   @,=&5X=     !#;W!Y<FEG:'0@*&
M,I(#$Y.3@@2&5W;&5T="U086-K87)D($-O;7!A;GD  &1E<V,         $G
M-21T(@245#-C$Y-C8M,BXQ               2<U)'0B!)14,V,3DV-BTR+C
M$
M       %A96B        #S40 !     1;,6%E:(
M!865H@        ;Z(  #CU   #D%A96B        !BF0  MX4  !C:6%E:(
M       "2@   /A   ML]D97-C         !9)14,@:'1T<#HO+W=W=RYI96
M,N8V@              !9)14,@:'1T<#HO+W=W=RYI96,N8V@
M                                                  9&5S8P
M     N245#(#8Q.38V+3(N,2!$969A=6QT(%)'0B!C;VQO=7(@<W!A8V4@+2
M!S4D="               N245#(#8Q.38V+3(N,2!$969A=6QT(%)'0B!C;V
MQO=7(@<W!A8V4@+2!S4D="                             &1E<V,
M      +%)E9F5R96YC92!6:65W:6YG($-O;F1I=&EO;B!I;B!)14,V,3DV-B
MTR+C$              "Q2969E<F5N8V4@5FEE=VEN9R!#;VYD:71I;VX@:6
MX@245#-C$Y-C8M,BXQ                                  !V:65W
M     3I/X %%\N !#/%  #[<P !!,+  -<G@    %865H@      !,"58 4
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M$!R0'1 =D!X0'I ?(!^@(# @P"% (= B8"+P(X D$"2P)4 ET"9P)Q GH"A
M*. I@"H@*L K8"P0++ M4"X +K O4#  ,+ Q8#(0,M S@#0P-/ UH#9@-R W
MX#B@.6 Z(#K@.Z \<#TP/@ ^P#^00&!!,$( 0M!#L$2 15!&,$<01^!(P$F@
M2H!+8$Q 33!.$$\ 3^!0T%' 4K!3H%2058!6<%=P6&!98%I@6U!<4%U07E!?
M8&!@86!B<&-P9(!ED&:@9[!HP&G0:O!L &T0;C!O4'!P<9!RL'/0=/!V$'=
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ML*"Q$5#PP,#Q48$Q,5$Q,8$0P,# P,#!$,# P,# P,# P,# P,# P,# P,#
MP,# P,# P, 0T+"PT.#1 .#A 4#@X.%!0.#@X.%!$,# P,#!$1# P,# P,$0
MP,# P,# P,# P,# P,# P,# P,# P,# P,# S_P  1" !E * # 2(  A$! Q
M$!_]T !  *_\0
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M8,2V (<&@[2.1,16;!W B %*L0W(KA_! @@80,54>01$O^M$/LY -;4F;)F
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M88?S</8N A=FB9&(, R91*Y727BF1*\[:+0S$C)NT?F9$(D=NF:4C#/G* N
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M(-(0:0@TA!I"#2$:HE$2GX 1$5C"/ "/Y#_7_P#&I4Q;H!UOGX? Q0G*_/\
MK"4YBM<Y2\:W"RP!((\C P\C(-AM<JUAX A6QA4<O9*5<JH-V+6.(550#N%D
MTS$2Y4$H=W&$X]6IHZ):B4C4FY)  #,[J6D N4N^263@B+ZAD=_4H1<N6  )
MN[M8$LP+OL"Y>\1,QN_/,[>?J;U] Q&1X)G%RZ-J9XP?&<HV!^N#O_M2SAZ0
M[*/8TQ,8\LBO7E79'GU30\BLV3>( ;D4O[0JA4R9)U'3*4J4&4L!24E20;5H
M& /RA(-F N#ML_LR5H0$H4'8L0?"% 6<2"2Y))U%[F[6#6=X2E4A9J:>M&ED
MQ!E.W3C=V5%E#Q*&/,H0BD8B2/L;4C(%EJI8#-12B+."ZQ6+AT@ZFTU%$G15
MQYSVQXY45 4I"E!2C=U+TD*8CPIFJ(!_F)*G)!38,<YV>[/F2LJ+%#$627"D
MJ4E8)[D L;, G2;%]HW;5(RZ"\C6Y*0AGXQ<C)O'4E"J-7C)^J^:ID<&8SB#
ME1LX@DVOC42!$2MB2ASMP*FL7QAQ>NF5RS_'[QE*UH+SE)"20E@%$DNIP$79
M!>X(,="I%:%! #=VZ.1 %KW!#$*RD.079V&C$(QKUT<SUV+=1 /K%63TAD5)
M(YY:(C56T>Y()1CW;0SYRJ!EC%35(@LK[3(;BZX)*HM?]Z*'!#Z^Y8O=-U.=
M19P-\!F87=7.= +N;Y-WOL"Q%LG&;D@P^G)6*:_B.MXS<2%<GKV$H\EADY66
MQXUCIAM9GD>F,;6I60N3R33OK9QY )"O(6)21^C*F_@D5FAT@'H7$>!T:I--
M-29:A,DRU@_P39:' )[LVTEP7TN0 68QI=)Q"<:BL0EV3/G(2Q5=(60DD!37
M&"!@9VCRLW5IUY4T(:K8KH>+EW+2PDLU_MUB%A,,V<>TCG4I&%EG=<90];<0
MEC8.(R.5A0&\*H)I,EH5LF=7LPE=PJ7+IOX292"+J595F%B#*2@CPN 6*G8N
MXBYI4*FU3E2R%$  )< ZB-;A*E ^*[K*0$O9B2R4Z -Q\)1(HFB/B3423%%%
M0B8"4JB*7:0$TS% #)D["]A1 O:7@ #0ZRTQ()U%)92BY)(=[D:B3F]W))8E
MXW%0TH2"#X98##9AZ.S<O(7:-UE+OXM_&2C=02_A3IDZ9J%4%$A'D>Z.\;'*
MD!@*L=%94Q>X.3"8IO7Y:ON$\7F<.FI(=A?2-2B$E1+D";+ )N;[6PY-A,<N
M'YW8>P+%[-X=]\74^(RA87+N:&93D[=/6%]()LT32\JDHQ///57\ZZKC=H03
M(S4HK(.X]L0.XJA9!%%(JGG(4^=D=I5JF35+*G5-F*2VIF45$)![YBHD$ .7
M/A!)%K27PH%2YA!(F*4LDI=)U%W+R[&[WV;\P+JDWV/YODL79,N07^S6N>86
MXD0RD*X:QHS$5C)VQGI!.??6]S:UV:L.E7D" G-+M.(R/*F;L4(V,D?77^P'
M;5%)4G7,%@ IUIL7&K4]4S,X()27_F(L=&[3]GUU3F6 Y+CPNXV%I3V5=V-@
MS$L8^@QD[9/6S=5%9$Z2B"2R9R'2 AD3E_AJ% ICE A@(8"\<E^PQ2C]H\?2
MM+62ZV6B:F8D]ZE,P.L7UC5@*5UNY_4\MF2#)6N4I+&4HRU>$6*#I(P!8AL#
MR&(Z)>PHF(0Q.2  G((AW%#Y 1*'''/H0$0]_E\\ZOM)3<7#&Q?;DWU[Q0PM
M86Q86C,'P'Y>@]?IJH8#\HF*ZF$&D(-(0:0@TA!I"#2$&D(-(0:0@TA!I"#2
M$&D(-(0:0@TA!I"+ ,0HF#N* \B80Y#GU_,/'SZ_/Y_S'4$@ DD  $DDL !<
MDDV  R8A(("BQ_,6L;^7GM$:?4+RO%53&+).*L#N5EU+LP8RU0K%C21D9& 7
M92<;*,YF)B)*/?3,,N*[=!2.?&\!I$469U@7,0H\A^T?M#P]%(:>FXG0S:E(
M(-/*K9"IP-RQE2Z@3'<V!2[OZ;AV2H9TZN2I=/-$LMXU2E!-R #J*"E@'U O
M9AD7@"D<Q),,>S>-J_.3X5*?*_=H1C(YX1D23;NS)*%7@DY64BFK:>B/%]7]
M.1!^HY759JV)VG+V:09_-D_BQE&9W$SO%N3,3*)F*2MSJ$Q$J9J2H$J3=E@D
MWNHCKJ:625)4M" M *-12C4$DAT@E&IB4(U)P2D$@EF1&7LT[*HRC5:3D/PM
MY($6:MW<F[ES,T4E3"1HB>7>2$HFV,EPFIY7KIP <BNZ76$RI]>G]H)M25(5
M++$@,4KU#FEE3E/=O""JX #Q>H1+E-I"20"  P%SFQ! MDCEC$=JR79G9FM#
MA35:&K+&F-'C*25K:1_-,'D9Q>54F%Q6 3G?_1+(HB<X?3?5%$A/10 +.OX@
M*F7+EHDH2$)*3X %:DG39IA#Z@Q!() )(2#%G(*_O,UDS#_%67"5-<D_F<V+
M9/IN(]<*&*[);"A+WB]1;!:EG.%EL,<G)RD?;Z^Q<$C63EK&H^-[7YE1HR,T
M*B!EV2CQDD\-YE [HX?2(GS!WL]%.FY)FS.Z8D@Z25I(N  E045 ,R]1>/2K
M,P(LE70,1N+@;L-B "1AC;K3.:+P^R0PR+#SRUE5IS%NS@I$(M1Y'L6K.$;P
MBZR\-8A1B%3.#HBD]>ICV*."*E9*_<4 OZWCW$)<U--K(D4H3*E37J)LN:A'
M\-*QW,Y22%-X5%" 4G4 $V-C14%&.\6J9+US5*6I)7+"G4H%CJ1J"@7LZBYO
MJVVYK-=YL%-78W2,IL] V-&<8PJ#:,BXB;;RS,"MT5&)#QLB+!1J!>V)?&EF
M;,[ I&I^7(&XN%<;,^F$N9-E!:DC4#,.I(\(9:=2E)(U $Z6& +A)NZ>D5+J
M@M$N8I )#I3J3=K@@)3T(8.Q\4(8VA)9^@JZ1:N%VS=RT9.735HN9F@[?E4,
MR:F4)YDVZSTB2IF34ZQCK)I'\0J@F8X:N)%55SEF7(G+&M2@4RYBP'-@2D$8
M(8_,9S$Z?)0"E4Z4E6-*IB$J2;ND@EWV8AW!OO&&3;$8(OF<@T>MYU!P@@ +
M$/'-&2*(@0Y5V;HJ2SAXJ4.3^,#&44[A(4>=>AI^[)1,="P2Z% )(!&X* LN
M79F RZA<V,Q)(U!)*3_-_*Q43D I& Q*MB&-FU$DC/ =/&JR2!6:Z8 )G9(@
M5%%"G%N=%LZ.F[5=%%VP<G3;@*A2LEC<<)"8/.5)92P5I)<JEE4Q.M@K2G2U
MR.\0I20Q "E#)$9)*TID2V8'NI8.+^$=<WY7:[A(,>RB+E/,T'5:8OTH@9F4
M;RSZ9.H899TXCW+0\<:1!8Q57+6/<)R+U8P 9!XTE&T*[,9Z)$QV+@TQ5)/!
M7,5)3;5-FK4@%146.I8EAM+EB5W<Z@X?&3I/?DO+*CEM+VY#\S%[<V<LS1*I
MM]W2&K>8HII79V^Y:DX6/6I5D;5:K6)XSO%>:U9H+*W,68W%_%UN&ITM!Q$6
MT%Q2&CQ>)>/7KN1,<7"INO<*^TVHIYB)$N:N:F2#*24*6I,Q$D:=3_?M*DC2
M%/W8#%DZ0P',^)]G4*G52P$H*ZB82X!*53)Q(0Z90NHJT@:RRK#5N_?#G40I
M=XDQAKW4Y;$R9RH-(>0GY)G(Q\_*N'!T48QHU;F%PB^Y07$$C ?@S=<H_P"I
M,8G6^!]O4UJ4]^H(+7,Q8#DW#ZZQ3&QN_38QK%9P1<@GPJ2.J2C2"6#'N0''
M)NA)8Q)6VD&3E!NNB\;*IKHI*I'(X2.50BH$[#E,4YBF PJ$ !*8P"8Y0 1$
MP<]+IJVFJI<I<JHD3%3):%E,N;+405)!(TI6H@@EF<L;.8UY:%2U*"@1I)#D
M$"Q9W(%NL;8*$$H& Y!*/'!@, E'GV' \\>P]A^NKI1" ZB$C+J(2&YN6CS!
M!P0?*_RBX! 0Y >0'V A\"'ZZ @@$$$$."+@@X(.X,3!J80:0@TA!I"#2$&D
M(-(0:0@TA!I"#2$&D(-(0:0@TA%!$ #D1  ]>Q'@/8\![']1]!_GI"//2PKN
M&$@BQ,R!^9-PV8A) 91@9ZKW%;$=))"#@R8JC_*02B8H_8!C&+KPFRITR3/0
M&!6F8$'QCPJ20%/I(8.06<."P,52ITOO0"_A4 H@I?P["[AV<@C )!$?*SNF
MQCEVC9ON46LBZB[%:;$27EF4 ]9-J?,-K7-SDC$3S9R*E46C$WTPZ,RBVCK\
M6<O)")=QOUK]^Q=B'QA]H7!.+TW%ITZ5+GJ\2BTK[R+A04DDHIW)N4Z01D$D
MI#*Z[V8KJ)$M"BM &?%W>UF(4I%PV[V!-B1#+F%3M,M6;+;(F*DI.NU8\<2W
M2:3-P4L4$F\/'1SE\AVJ* +N035:&7%04W#Q-9!)110HEUS84/%I8FS#)JD&
M8'4%)GN2LNI2UZ4%G.5!67(O;:45:%35$*3IF3%%!)2'27*6=9PC&G;#@-'
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M,DW:,S;AC0/$N6<@T*H1=$#7?%N%S009"EZ% :M!(!2HC429<L I"-8NY?2
M%.$G"_BDP*.D$Y:RFY"XF'-O<CK&W?L59"P%+4^-L=H:5*[V)A*/I2N1<HI(
M/JE%INE$4'-G>0ACL7?XPQ3\Z2#!<TDV3$QET?L/Q:KHE<.D4T[44S%RD3)B
M5696D$ZDL-)!OI*R4EO$JZBIB*I:IV4S%*5J2_B4I1+AP202Y!=0/-4>Y;Y,
MHR+US'E(RR#'N:Q N#LW!),L*WEJ^Y0=345)R$Z>P&-#R!HZ1</YLL6B<C5Z
MDB^;2+99"KQ^<X5VD7)F"4=5D@W"P+\R9XL;,= \)<$Z@!17<(3/2ZF+D$X)
MO8V5+Z.SD>@>)1M@>YN+O=YO9K@1.K2;2/3!HPC["U+C./@2SBC.+:QK.46;
MO(1&-.6*BX]R9)%!R95@@GR9RBD/;^QG:J5WR!-F)2=,M("IB4I?2'NJ>2SL
M H7L"[-&C=H.SAIY(F2D%1(=1T$J(\1_DDI<N XQDLYB:INJ@9 W*Y#$2)RL
MHHL0QB 0@&$ZYQ]%$2"50YC<"(& X\>M=ZES9-;*U2U)6%"X!2H@J%@0DK;(
M87VCG00N6H @^K[<[#W;>.B4.  /T  _X!QJX2-*4IV  ]@T5&Y)YQ74P@TA
M!I"#2$&D(-(0:0@TA!I"#2$8Q52#GE1,.#%(/)RAP<W\I!Y'T8W^$H^Q_(-(
M..<9-(0:0@TA%HF*'R8H?E[$ ]_I['1QSB"0,D#SC0>."M$73LA4C*I)JG A
ME4D0= @W.J1(5U3 FW 3"!164'L)V\FX*8.*)DV5*#S9DN6&)>8M*,9(U$.P
M9^3^L2A*YBF0E2U%0 "$J62Y "6 -U6 ;)Q?,:.7NH;6,55&=>!1W<E>(V30
M9O*8A*&52+#RD6N\BK/&VHD.I$3[/ZM:,CY6.BG3MW$R3Y&+=F(\.FDIS7M#
M]HTGA1GR0$K3(F392)EBE24&RT+%;+2Q8*!"4DI8Y(;8.'=F9E2L3 #J7I4M
M"0HS$E1!4E23)400Y20HJ2#L EE-^D,][7]SPHR%VQZV7O"5*>-*6\1E_'59
MZTLFAI)&!@%E7,6^=3$!8Y J<:X;PDFBFJ^!9%587"0*<]E]J>"=HIY-8NA2
MLE8(7,I6)+ %IM1-4"E5R257 !%R8SD[@W%J% $JGK"D%.)$]P &+*3) .H#
M("3<D*PS$\XYMAI"U2+R7J=GCF0G2@+QB&GY(;FH+?&$:J$/)1 3=;BUG*II
M"X-UI)=Y)1J4.D_.[CTH:0>$-+!H_':NA36S9<J1+^[B>J7KE(E&4J4DD:@M
M)*%(405!0!2[ELMLTE4Z71TY.HSTR$%UH4I:)W=$$*#H4%(U%!<I7I)"U.50
ML=UQ!BJ9=T;)$Y?<+8!L$Q0J.?'%(QU *Y(=R:(*)$_&\A,18R*]@:QQ$#02
M!6!W9CN4E5W[M9<#J#DOPS@-71B8*KA:*A2!_"3/I3,#6)4@(F3 , W)>[7$
M8U?%>*271+E5LZY\?=3B07_*.Z6@-=PR6V-AI"!Y7?MLJSK">/,X^C:*^1/'
MN4*?*1%?A[ZO6G5LDHZZ(P#!81CK2U.XCDX-Q/A&RD5.OC_0,G=;?QRBNF\7
MX=12D-3U%.I024J$B9(<ND@ITRT!3E]+," %)N T9GAE;6J*#.D5* I*23-1
M.!#MDS%J?#JU%R;DDF$F8,; ^M%9H82;VR%H1Y!S5JE+IA6:Y?Z$Q?!.K/8Z
M4CF]61BF<BVBS2R,Q(R[LK@ .V;R#DY3*FPO#)LRGF:5"8D D#6E024 6(40
M@;%G)NX)()C8YJ),]'C6@$\U(!)-BX5J-W-F;?(:$BO3Z-LL],2L8K&QL0K$
M'DH:&+-/WA8Y!!R"*5?3;3*JB:;DB/;XV17KY04B 8CAR4I5E-=XG5SY]74)
M$R89?WF:G1WB]"4:U)>RU,S$Z0AF8@EVBZ1*2B6@( ("$@'+A*4L0P +_P N
MG+6 :/+Q\(XD&<E) S2<0\0LV7E?I!!BZ3;G608I& P\HE:'>NVI5%4C&;=[
MA $S@"J7=:4LCO%!4Q82 !JUS4BRW+A10< A+K#@ !1"L03,!.E"[X 2JR4Y
M/A.^<L.HA3L80U0/8+U#Y*OCZC03*GW,1)$@[?R%@L";9%"$C&JK)NYBG[4R
MJ:B:P)K%<*%15[P(<AQ)L' Z-*YU4@J2I*#,2\L]Y9[*4=+.I1<OI(=1T$,!
M;5]3-(DB4C6I/=I7<^%BTQ])5<!R$$,I0 )2Y4.O7J9"M9Z6H2,[2K9*6RNQ
M\%5Y"-B;U8$VC^<D4E%XZ,CJZP>%7DFY7;U5](,/.T8.6CED!P30/Q=*H::9
M6F7+F2535>%*$%*IEU$*'=I05EE6(/Y5.FVWC45U0*8I2B85$7 "BJR>BG)M
MZF^Y$*7/;?LHX%=,[S S_P!8^=3J[2M2M=\L;*.X-1>0;)6YY%R12K55&3=L
MX29:/I]!!G+&<-CL55"KHB;-U?9X<*EIJT3PI2TB84]Z P(8#3W,M22" 6*G
M! 2V0,3+JIE4D2PF89@"4KED**D+(&I"P%*!4FZ2D$@$,5%G*"3F4Y9W63U*
M+G+"RK#IW)V:<%X^54E;5*/@146D)EJP040/YQ5;RD0FT5030<N1+V]I1#6K
M3^T%0Z92)>L:T()F@L2K6+ZYZ0-+*<@#2WA&D@G-4?#I0(-24RASF%*  XL\
MQ!9P,%[7+Q4\3>[%&S+^6D(H4YY5G)J+V=W'DG[*_ASDC6H1JLD[!58RR4X+
MEE(QX*1CN+C'7 J'14,7UEJJ^+H$N73S5ZDH(3+DS207=M'C(8. D!)! "B/
M$F+@HE4BE*6I,N4ZM"UJ2F6M%]*DJ("2DAE!05I-FR&<#1=OV6[K27V2W5!4
M9PEB7:URBIQ-%7<J2,DJI*HLBP:)4 2BJL#TRL5(3=J%K'M%$T&\<Y6.! '.
M4G9NLE--J:2HE!1L9E-,ELDAB4E<@.,@DD[\FC"5_&I'BER)\F:1D2YR5D%W
M#I1.L_\ 3FT)=;H]7'+R._"(-]4;:W4;MV9HFPIN7#8U7:Q$XA)6!DDU1DY^
M%MJC]N]8O5)J3B))Q'.5&$08J!D"VM16UG"IQ[A,Y.E:@@!,XOH4UC+5*!=)
MU$J4  +)+$"^(^_TDL*22\B7JL[:D![*$RXZ @ \B\3F;&]RUYML5&-,GS\*
MA732C>BTU5-%T\F[Y8I*:>'0>$\#1HBW:((IF4<IIL6J3"/%$ZK9H@(%)]"_
M9CVHJN()DRZI4Q*2"&6)@_F/_/4+!O=\@,&LT<O[1<(ETBEK" E1+DL$M:['
MNT;  !V>Y )<2W)#W))F$.!,F0>._OXY* \=_P#CX_V_\7S^>N[.#<%P;@C!
M!P;6]HTDD FX]XOTB8-(1:)R / G* ]P$X$P />)>\"<<_S"7[@+\B7WQQ[T
M@XY]/7E%0$! ! 0$! ! 0'D! ?8" AZ$!#V A\Z0BND(-(0:0@TA!I"#2$:#
M@HIB44DSJ'$RA0 5729"F7\BA.XR"2H F=<"$55$I@;I#WB @7M,B+_%M\.]
MO<.=@[,T1]/<N=3=L]=MXO97MJD8Q!RX1CI!]O.L42^?,4E3D9O'L4EMMG4H
MQVZ;E37<1Z4W,)LUE#MB2C\J0.UE^F?K;X0'D0UA8'G_ (ATRT:@Y=ZI \B&
MRK:T4!^"CO1M9Q+S\ )@VR$ W;\";M)W?(%+\!3XO\/Q^O7X&*K=?86^/UT@
M_M<ZI/\ X+-K(_'_ *Y]L_W_ #MF#_K]=3?I\?H?%^D0&W<>@_\ +ZOT>PV6
M>J&8/NV7;6_GD>-Z-M+P;USP ;8Q#UR(? _E]VJ9)(4LJ##468DN+_M;;D(\
MISZ1IN7WMRY*'5^@ZPCF4[1U?K='&CZ9M9V?TH'#-]'23^4W1VJWOI%-X8YB
M(-$EMLB+5)@*(^)\WDNQNIR*:2P%$A]8[BLE4]'A?8#2ER[G)R V<BX<#>_X
M9-13K"YC9"RY)8@D@AR05)+:;N&&EV8L/R'LWZCF4JI%P,SM&V<5QW"R5>D4
MY6D[EL@5\O<WA B+ TB*X;;\\JU?;2SUK&^9.-BVZT>A'@Y83*Z)TI$W/N*_
M9_3<5EJ,S4#.3K),B4JY+:65*(#@E1+DA0  *"5C8N'=HET=4M8/AUK9U%B'
M+*)[QW#6 L0IR"I@$LK73VZJE9+8F\%C':<@C968,WCE]G"[R3QL02JJ^6)E
M9;")YF)?.^V,*^>IF5<"LU.=5<ZQ3&#6:?[)Z2D7KEF=<I4H_<Y(#EGQ*)+.
M;D@EAJ*=1T[+5=M>\0 %)+."$S5$D)) Q- OR&<C5X27 3NV+JIOL(5["-=V
MZ;2JHTASHG/>F^Z"Y2MQ58-IA681@PE7VWWZ])L1=0"E[1<E[4P,"AAY$^Q3
M?LVH9\F6D@/I!*C)D:B2D.%!5.=)!=TNJY+DD/&MGM(KO53-:BHLG2I:P@ %
M2@0!,R00"HL0P "<'V5(V9[^'--6@\S;?MH.3WKIR+](\[NUS)%&(L=.79NT
MK"2 VC/TIA%\W51CY-JU>^)W G:,DSG6F;4Z;><C[,*"0KPA*@2Y*I<E!)U*
M!L*13A@E[X46<!U2.TZB7*E)+\R0X8I-YSN"[.&LY+EH0*X=+OJ&V5VY<L:-
MLVBUY.8L#Y^Y=[D\W.Q.WE2QJ,;& DSVGHH(1$"H@?\ !TVZ1%DV:9/JNTQ#
M".%G?8Q23YT^<KB<^3WL^;,$M!EJ3+3,F*4$#^[HTB6DI"0 PN'*4NJ\3VL4
ME*=+D!(;Q+2;)=V$PAW!P3=@#<-8YZ:757?*1!GTEM)?_@T.: B/K-R6?138
MPA&3N/1BR$0VJ)>)HDS=^ B/=V@FGV!R'K5(^Q6C-SQFK=F9I3<K$2 7N2";
M/Y/#^UB[VQ_C5=W<_P"T8FV ^S6SXHO24ZDB9")IQ&RE,J92D*0NX;.O"8$
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ME6 %0YX. 'Y .E@, '%@!N>F;OYN?,QJ?_3O8L,9YN#D]'BHW+JW\^MO73W
M 'T']['<,/K^O]T .?ZB4/\ X0TAZ*]__:*#<NKA_P"'OI[_ /W8[AO_ .00
M_P"N/S#2'HK_ +O_ &CVF/+%U(7UTKS;+^$-ED'CQ5V<;-.8ZW)YLM=S8-/&
M8R:D-7['M<IT8\=$5[2%*M9V9>SGDY0#G4NV/V/O[Q+=#^O0N#RMS;)YOK(
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MCMM1<-W"RXPN.YV_NI67:A)7;)]/6A[&SHS=:L3DN%=I%AJ+\E=F:^%F<O\
MZE54\Y))?W+"UN>6]>8 #& L,^F'O8-S].1>%CZ@&PJ;V88$R)O Z;.4,P8
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M@7%W.V>=VM;?( W9GAM&^+:+;,_]*O,750EV,A%[F\B[E(_>Q4)-J#A2V5/
MU>?Q^-<1TA,[<IY) E=P^QC\B,$$P)^!BZ>*2HMW;=P=,S>=[\[_ *%VRV.;
MSDL-F'4_N>0 \F(B6#I^Y\3ZH&[W&N\9D5%[C3:CLSI5323:$\D+%[N]R#1&
M5S:A BH8[5%WCRF5<M<=).#C(-6-JBSK)()2[0%V2.FW6PY_*YZ"T07#WN3G
M9LM@8OG>W4_187M(0@&["\@4H  =A1,(>BE*;V "//:0?8!Z^=(,.0]A'RGT
M-9$W[6)GKM52-V[*81(P H4>%2X\Q6H9,W!O1RI_>8@\& GWB %]ZC<YN?T'
MPBK889O+!(^'UB/JO*9 .#E,D'E[1 Q3$_B>7D2"!@'[O((")1 1[QY$.1YU
M/Z13;//KY8^&.G2/B]V]X9;9P_:3>IO75<GYHQ4##&:$F6:P?D-UCFRO5DB8
M&03C)"6;LG@*0[HH'752 H"HL4H?S\&*W%VZWL?1_P#/SL)L=Q:VQ^+?L\./
MZ_FSE#$?2MW!7ION;WEY%5@Y[$K1>GY<S](WNE2Z$WF_'48B:P5U2*02D210
M*HO*Z*JZ;EL[70.ORX4,4KD_I\7;ZV, SX ;+9O^GGGIO]!FQ<"DV6;1P#@I
M"[:L*]O)4DP @8YK7:/:D8R)0[>!X2,9( _D,8O B_:(&?\ O\OS=?UA,-]G
M3OV\=1#%CO$^X6L.W+1BN_D:3=*PY)%WZASSA-=1.?J=C>$D2L5A<C'G=1ZK
M,\5*FC6\=.0\Q"(,RH3_ $;/4/;ZWOM"X>SW)PW^>+D.>0N##(<9=,'J&8RA
MFN+8GK-YL?8*8A^%L8F=VSX9M&<6561*JT;U]MN!NL[:9\@-X_P-&DG(5B;,
MQ%$KB#CX("H(I0?/]<^O5VM>T2#_ (=]RWNWDV]B/16<Q=*"MVS:I*;0,/Y\
MS+@FC9$F;#-;B+W#D@K_ )CW,2-I9LF=JGLL9,NZ$G(/G<^=1=>QM6;:///M
M0/7&#*/K[1),1:S._P#E_7<WR+X7W\ATS??-O)_=X>US;]=]O6 H' MBS=8<
MN!2:W'4RB7BS4+'T!)5FKP,*UK]2BW,;4HV*KUC<5U*/;+HOY6)%_("1-Q+H
M@HNJ!98LYW M;S<6=K7-OG%+A[, Y>_/F;,<VNWH(BRGNB)?9O>5_?Z9=0W<
M'7MS:8ILFMUB,7X,BXTE<:ULM7:5J3IK.I%K]EA5X9O&1LG$S)"M)+M>3#Q5
M*5 A4AVOG/3Z\O)XJ&X8L,7SOOU//S:%JSUTM,UY_P!P&(-P=@ZB&=ZK8]O4
MU,3>$(&H8NPA&UBDR-AB6,)-._PK]RW+6<&P1:4C%3IK*G+F.Q<)$9$B$5#(
M$CZQ^C_!_6(&[ \[GVN?7+$;B\2I15'%UCQ*@9*=(904=5<D!=):?KT>T:WQ
M8\:#*8D92"9 :%8M994[DH0+,BB#-$Z1&O#=-,22;AW'ER+[#X[#UAN+$'WV
MRY!N]N9R7$,(Z='36QWTWH_<92<3S,G,XYS+F:7R;5X*2A&L>^QU#RD!#Q#>
M@%GFCA5Y8X1DNW,>*E2(INV+)LFG(C]4+DP&'/Z^%^F.1>!)+EBW3)]"X R]
MGZ !HY>Y#IA0.4=P4)O$V]9?NNT;=M%-1@YC*V/(BOVRKY)K383(M(3,^+K<
MS3KN26*2!6OTJA304NS%!-=.P.WD?'.#B 2]A\<O@ AMK$\NC2Y%F) ],,Y)
MN^2UN;/OX;)O3%S%N[3@ZIO_ -Y<QGO!M?FXRT?W?,082K.W&BW>PP3KZF)=
M94L 67)U\M<1Y2E?&KM?M%$8MW)A2>C,'*951Z_7UBVYN+N.<.XW].C7W:[#
M>)!<AXBMDEB1IC# F1%=M;J%:P4+5[/4*#4;:C6*W"(D2;U^&IEVCUZN+0T8
MJ9F1ZNW;*QBR28,4143!(#-86'ISOAP';;8YWB,Y!<^=][XYW?)>T1F[!ND'
M8^GU;;5,8HWJ9BLM/R?D!#(^7J!<L6X=499%G^Q9TZ>.;.2FNK77U%CO#D.2
M)=10>0ITDDDC_:$8^/T=_E\HGH1ZW+6?DV69_P!HFZ1[O"EWE[3^)/O*"BBH
M%-V!W%\JI$E5.!Y#R*)IJ'_F.0AA$H(F(UNH)L+O&_6CS^&)#=1D3"N#KE#L
M(O(./J)CW&TXM=3LI<\PFX6NUBA'MOBTB$:L4U8Q@[;L%#ID23.8!%/4^MFQ
MZWW^F?RC#EG+Y#X +='Y^@\_:;%MI.2]E^+XG#4]N9O&?L=46JUZDXOA+ACR
M@UQ[1JW5D'",>P:3]0CF<S9"#$ECXQ-*QNE08> Q&CYVKR<\>H\M_KR?T@?6
MWJ]C]7:[9W?P0@)D(F43"4A2D 3G.H<0*   G44,=10P@'W'4,8YQY,8PF$1
M%$Q%7O"Z6^+]SN8JKN;I=SR+MGW:XY07+1MQN$'T<RMCQJV9JH-Z[D* E6R5
M:OM27.HWCG-=G5TSO(1%>+))H1T[.@VCR]OZ7#/[=,Q'ICIN[OU\_C:$<SMT
MVMZNZ[$EDV];D^HNA8L*W.+B8R]1F)]HV.L87Z_LV#^.D2)2MSEKY=HR%4!6
M-3.X&"JL0U46,;Z:,9M019)^H4 SY 9Q9LN Q(\7, 9R(D&V#LQ?KG+XYMY$
MP^."VH2N(-JF.MJ^VG,=QPLUQ=5*U3*MDQ>JTS)MO5K5:(*:S:2CK9%_N@XE
M9=)905I((Z-!H[.HM$1Z"1$VY(U7>U]C@8%S;+7&&-]XA^GM[VS\88UT_P#I
M V7IWVZUR6+-Y^5[-0\E7-#(>6<<VK&&)7+.\6-J*QQ7)9TX!2R09UBNS)'"
M#6BR' IO @@'\--J<G?D_5P22X8D&^V,,(DD[@<R;OZ!KQV,S=(Q6S;\B]1+
M;_N;O&V_/TQ7HJMWEHTQ_4<JT"XQ\7 1M6(DYA;4Y8*QRCN%B(IJX=)F<* L
MS)(E3(L4YP:BV<ACE]QBPL+ 89AM:'V;RY'D20][^@R&RX3>MTYL3[V6&/K%
M:)2[XNSYAR12F\-;C,6OV,-EC'DJ19)1TFS=.#.X*9JDNJNNK-5"9+]$HF"J
M$<!4TTE!I/\ GZWWO:X?R]5W-N=F_5_+/D]BR.VW87ONS%25L.YQZG=A?XEF
M6B\5=7.$]L]&PIFF^UZ0;)M'T*_RH-UO$55$%6Y1)(+T_'D'(3)G#M0SMEYC
MIEANI/H _I?Y^FT3_P!(Z7Q=\M?G@7:^8?KMMVVXBVDX>IF!\#4)M0L;4QDF
MTBX1@J+IPY=.%57$G-SLPLH9W+V>6<'5D[!-/U%"/'"H,&ISIE0(G-O+J?U
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M$H ('$1[M3]>[_7[1#%CS)<%K;=3YCD&Q80\%$P'22.4"E Z9# 4ABG(4#%
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M-,9!N+.I$=6<QI)FZ;"C7&\M/SCA8BWG6:14&\0^DFY%)#N5.F!SK'('G43
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MRL>4,/'KC9P213NTJ<ZX1<7&0B9X9,SILU2$P33:1;F;&\"B[IT8JBV-[?\
M#:>DX=HX=P^97K2BR*.C35*>Y*!+IY:%MI((\)4<-<-[< XK,37A=2M,E"E)
M,Q4Z9H<"R25KFD*LD.G7I 4^7A#-EVVJP%KDM*9%HS8(*\5JOKN53Q4K&R@N
M9Y*2LSY6MK@_B)BG/6L^=)]()L&K!%.46(G$(08<3\AJOV<]CN)5**BNXQ3U
M'#T+(532:^544B],Q2"E,N75TRE!*0%$"4L#18*#D*R_&^+&M4N2*M&E)5W9
M^\'0M"3I!!$Q2"E0+H &DW4E*@D@)]N0L.5,NY"K.P1T[7E9D+W$2$S>5Q.<
MTYBM!BG86,E+MF:9/-98-NLV8SS@44V,G*=\D!"@X* ^/'_Q.N[0'LS+GI6$
MS&2E,R<HKEDZ$J6E(4&!<:A)8J4;%KXFCIS(0*OO F6$D]X%%+LSA]"3?2[.
MY( -XFMH=+@Z-3JO3X1J1O%UNN1L''D402 X(QS)%J59X % %'2H)%474, >
M58RIQ !-SKN7"^$4E%04-*JFE*734E/(6M4F62M4J4A"E*49225**;J4D$[B
M[1@JB=,743E=XHA4V8H$+4H#QDI*5.Y#$Z5#9B&W[J\5'+ Z [!FI]29-5P;
M\,24\XI%(FBFY0%(!>D(E]A!$3B@  41#M VKZ;0T927I9./Y:>4JX<#PA!?
M-K'F&+$>0FS;:9BQG^=08$^)KAG(O@$W+[PV=3/;S3*?A>P9 H-3KL"[D+BQ
M7MISP[8[J56G'0-&BL<]2$J<>L@_.9P*9A R@J\&* F#GAOVN]FJ4T4BIIZ9
M*$*TIFSI=.E"92U=ZKQS$R&00)=RM3@Z;JR-W[-]HJM,Q%,HJ4):4RY8!F*=
M"/"+=_=K!PD,2S"PA+]LW3::7&B8RRVEE*WTJ6L]<EIB;"O-V)7CB-L:3EA&
M,6JSU%9FQ35A' $E2=OD5*"P(F[0[@PW8K[**'BG"9-9,F)'?(\,QY2B7&I@
M_#YA8*9P%$@J>YSE./\ :R?*U24G^(E024$K2H$@+/A^\!6&V9V22+D315C%
M50J2:#F-@4 ?)1T)&.EB,D4 =_NXF5-A)B46GE)(E* ^11'CZH1,)>\>1'N7
M#>R7">'T]+)3)DZZ>FD4Y69=*RC)EH1K"A3H)*BARIDB]TI<B.>55;53UA:I
MLQ6LE129BK!9)*3I6I@+AE>().E5LPQ;NL>1$UNB:5C#=8FWL]++%LF86;"'
MEW=>_>Q)(TC4C*+M(>4>UZPS)$T7#)]'23**'S C-I-'1S%)Q#MSV4J*SCQ7
M2\*JYT@+3_$D</7,D ZRZ@J73KEV 2IW:XLV-WX-Q-,JDTSJZ1++LD3*M*5A
M+%@0I:2&<I%KL[J+N^V/Q-9<48.97&#C82N9*Q]67,T]CFL8BRB;#73E)-6>
ML79 B[B,F)9ZH+MX^G1=G<KS@+NV:_TIA$W2^'<+I^#< _%ET(IIW#J$ZDKI
MY4I13324JU$*ERR0L)<DS4!3FPLVL5!56\47+34F8)U5," F<5DE4Q6@I*2L
MEV&DI2021?!AL>T%E);M]S5QW?6)@I'4>DF+1<759RP+XX\?PIL=^HY<* O'
MG?QB<@#@XL554DWZZID#E()3!H/8[O>V_:6=QNLX7.ETE+-*7G42D4Q,I87*
M0I2OO<I2PA064F:E3:2  L@Y;B:E\+I)=/WRDS5H'@4M8F*!!*R$DRU:5*!3
M8$7*0P$3'"Q0=)G;N8])0!%4%0.T+XE$E"$;KIF[RE27!5BOX!$ $B@I*=I3
M  @'T$FGI)3A%-)8#2--/+& &;PADN!86*7&S1J$T+4 OO"%*91'>:B"=0(.
MDEB0-RZ73XB7CQ5XQ71LB5Z5J]OJD;+P\PD5DNV<Q4>N"")2D*B+106ICMTT
M#) [3 .03<+'  Y#LU8UO"J"M243:240^>XD$GSU(7[X/RN*6KJ*=6I,Y=AC
MO%@$#9M0#^F?5T+IVUFO15E?RE@@:O(LHN5DT\>&95]JA,P=0L$&E&2=2LL@
M^%<DM!QXH)-H-M$+M5&K-%L4Z).P2IZRKL-P]4U4PRY("EK6D!$BP47"5!-*
M"P%@ H,Y93.^4/':D@I"YCZ0@J*IK>!]*DA4T@*)8OH+BRAB%LQCBNL8H9R\
M13V#M@QF9^3L#U%T]D7Y0?29!<KE9*._,5FR*X4,5NT3<'30*0J*:A^P-;+P
MS@]-PQ&F2E(O;2);#9V$J6K#EKEF!)C%UE5,J2"I6KPD7<D#+6)#VN^ESA(=
M@J2:JO(@9$Q?8CZ*80Y'GG[A_F_K^8<<<:RBBSZ03RL]NK8M\8L4:B;@^KVZ
M GZ(C: >0]A_4! 0_P"0Z@.1XAOAOZQ78;>P_I%=51,&D(-(0:0@TA!I"#2$
M&D(-(0:0@TA!I"#2$&D(-(1:8H&^?^O\M4J2%>?UF$<9U#MWIBF<-FZYD%P=
M-Q7#S @[3 2HND060.5-4B9N ,GZ((F*4>0$=64V@E37) ?.00]F+*0<,S%P
MS6) ,3J/('J?7;'+I86M&4R:2:":10$"@X P]I *8X@4>X1( %^\1X,8.P *
M/Y!QP'K.0$RI"'LA<M(Y^%) PW)[ ;L!L4HDAR3X1=M@2R?3(\[1#C13D7ZN
M^63.0\OT>/6A(@RW/>U.:F8]57*B"@!_KDWKPQ0(')B)*F .Q,PAPE+?Z678
MD"6"QL0]06LS!@Y<[7!$;=-!/!4A1 +)22DV(!((MNIF.;DYQ$SQ>PP )/$8
MHB)0$/?(EY 2\_[0<& P?("!N?8#KOIUI%P.>^#=_)L=&C4,Q<!DA[Q R8^,
M1!00$O\ #-V%4$#\?RCV&(<0-P/88IO@0'52?$!N39A?TW]H1'1U06CU_M%O
M QX@8K2Q4R1>+#W&22CV]D9_4K@H =A01$2%4/SVIFX QBB( /,OM6ESCV4K
M=#N)J&'BWDSF+,7(!:UM^<9_LTE^*2LO;&XUHL QNP?JW*/;=/F;/.;1<.K*
MG,92.A5XHQE1$%OI8QR^:M2+ 8.XATD"MR'*;@Q![ ,!1, :N?LL7-'9"C$S
M(!:RK'NY1#ZB+B[D-D%KP[62=/%2U]005#=PE2";#=DG<.#<M#XNXO;P<Q0,
M! ,?D0#@..!-P/P7D!]B !Z'70VU /N!C],M& CDIQK4KAR^;(MTG3U0#.G"
M**9#R!FZ8I,Q>. ;F54(V0*5)(_>)2AZ*(_:4?!=,E1>SN]VN1<.=).P=@&-
MV> 4UP=_UW9G'Z;[PB>Y9TO';?,UN4%/"LUQ?<E2'[C=O"=<=?84Y^TP\&.)
M2B( /=\E[O6L!VR/=]D>-IP$\,J@V00*=09R'/G;RO;)<&8\8X>;?[>62W_[
M-N0#AG/K<0U/I7"R0VC54B8)E?K7&YC,%1X.K]<2:<G2!T0@B=-<T*G%%[%
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MJFRY,Y!,N6$G1-J$+(400#I<-@%P7:JDF3^*H,B3,G)7+0$JDH,S44K45#P
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M=$AC@')BE$> 6?\ 5KVQ;]X7;9[[G?T)Y1[,!Y !]>P ?0B(>P_(1 !$/\Q
B!_R#XTB8KI"#2$&D(-(0:0@TA!I"#2$&D(-(0:0@TA'_V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
